"PROTOCOL","PUB_ID","TRT","F_MITT","SEX","RACE","SITE","CIRC_STATUS","AGE","F_ETERM","TERM_RSN","TERM_AE","DISC_RSN","F_INF","F_AD5","F_HSV2"
"HVTN 503","503-01743","Vaccine","Yes","Female","Black","Soweto",NA,20,"No","End of Study","No","Per SCHARP administrative hold on product administration","No","Yes","Yes"
"HVTN 503","503-05616","Vaccine","Yes","Female","Black","Soweto",NA,25,"No","End of Study","No","","No","Yes","No"
"HVTN 503","503-07058","Vaccine","Yes","Female","Black","Soweto",NA,34,"No","End of Study","No","","No","Yes","Yes"
"HVTN 503","503-09586","Placebo","Yes","Female","Black","Soweto",NA,27,"Yes","Refused Further Participation","No","","No","No","Yes"
"HVTN 503","503-15056","Vaccine","Yes","Female","Black","Soweto",NA,32,"No","End of Study","No","","No","Yes","Yes"
"HVTN 503","503-10430","Vaccine","Yes","Female","Black","Soweto",NA,34,"No","End of Study","No","","Yes","Yes","Yes"
"HVTN 503","503-10066","Vaccine","Yes","Female","Black","Soweto",NA,29,"Yes","Unable to Contact Participant","No","","No","No","No"
"HVTN 503","503-08488","Placebo","Yes","Female","Black","Soweto",NA,26,"Yes","Refused Further Participation","No","SHE HAD A PERSONAL PROBLEM","No","No","Yes"
"HVTN 503","503-13684","Vaccine","Yes","Female","Black","Soweto",NA,21,"No","End of Study","No","","No","No","No"
"HVTN 503","503-06115","Placebo","Yes","Female","Black","Soweto",NA,25,"No","End of Study","No","","No","Yes","No"
"HVTN 503","503-01926","Placebo","Yes","Female","Black","Soweto",NA,21,"No","End of Study","No","","No","Yes","Yes"
"HVTN 503","503-11563","Placebo","Yes","Female","Black","Soweto",NA,20,"No","End of Study","No","Pregnancy","No","Yes","No"
"HVTN 503","503-09511","Placebo","Yes","Female","Black","Soweto",NA,22,"No","End of Study","No","","No","Yes","No"
"HVTN 503","503-15704","Vaccine","Yes","Female","Black","Soweto",NA,21,"No","End of Study","No","","No","No","No"
"HVTN 503","503-15154","Placebo","Yes","Female","Black","Soweto",NA,21,"No","End of Study","No","Pregnancy","No","Yes","No"
"HVTN 503","503-11043","Placebo","Yes","Female","Black","Soweto",NA,22,"No","End of Study","No","","No","Yes","No"
"HVTN 503","503-03229","Vaccine","Yes","Female","Black","Soweto",NA,18,"No","End of Study","No","per SCHARP administrative hold on product administration","Yes","Yes","Yes"
"HVTN 503","503-10024","Vaccine","Yes","Female","Black","Soweto",NA,23,"No","End of Study","No","","No","Yes","Yes"
"HVTN 503","503-05856","Vaccine","Yes","Female","Black","Soweto",NA,23,"No","End of Study","No","","No","Yes","No"
"HVTN 503","503-14633","Placebo","Yes","Female","Black","Soweto",NA,25,"No","End of Study","No","","No","Yes","Yes"
"HVTN 503","503-01495","Vaccine","Yes","Female","Black","Soweto",NA,31,"No","End of Study","No","","No","Yes","Yes"
"HVTN 503","503-13012","Placebo","Yes","Female","Black","Soweto",NA,25,"No","End of Study","No","","No","Yes","No"
"HVTN 503","503-09658","Placebo","Yes","Female","Black","Soweto",NA,28,"No","End of Study","No","","Yes","Yes","No"
"HVTN 503","503-00946","Vaccine","Yes","Female","Black","Soweto",NA,31,"No","End of Study","No","","No","Yes","Yes"
"HVTN 503","503-04660","Vaccine","Yes","Female","Black","Soweto",NA,20,"Yes","Other","No","","Yes","Yes","No"
"HVTN 503","503-07352","Placebo","Yes","Female","Black","Soweto",NA,31,"Yes","Refused Further Participation","No","Unable to schedule","Yes","Yes","Yes"
"HVTN 503","503-03620","Placebo","Yes","Female","Black","Soweto",NA,18,"No","End of Study","No","per scharp administrative hold on product administration","No","Yes","No"
"HVTN 503","503-04637","Vaccine","Yes","Female","Black","Soweto",NA,20,"No","End of Study","No","per scharp administrative hold on product administration","No","Yes","No"
"HVTN 503","503-09423","Vaccine","Yes","Female","Black","Soweto",NA,21,"Yes","Refused Further Participation","No","","No","Yes","No"
"HVTN 503","503-10414","Vaccine","Yes","Female","Black","Soweto",NA,30,"No","End of Study","No","Unable to contact","No","Yes","No"
"HVTN 503","503-02834","Vaccine","Yes","Female","Black","Soweto",NA,23,"No","End of Study","No","","No","Yes","No"
"HVTN 503","503-15859","Placebo","Yes","Female","Black","Soweto",NA,19,"Yes","Refused Further Participation","No","","Yes","Yes","No"
"HVTN 503","503-06274","Vaccine","Yes","Female","Black","Soweto",NA,18,"No","End of Study","No","Unable to contact","No","No","No"
"HVTN 503","503-01854","Placebo","Yes","Female","Black","Soweto",NA,25,"No","End of Study","No","","No","Yes","Yes"
"HVTN 503","503-00140","Placebo","Yes","Female","Black","Soweto",NA,24,"No","End of Study","No","","No","Yes","No"
"HVTN 503","503-04461","Placebo","Yes","Female","Black","Soweto",NA,20,"No","End of Study","No","per scharp administrative hold on product administration","No","Yes","Yes"
"HVTN 503","503-02750","Placebo","Yes","Female","Black","Soweto",NA,21,"No","End of Study","No","per SCHARP administrative hold on product administration","No","Yes","No"
"HVTN 503","503-06903","Vaccine","Yes","Female","Black","Soweto",NA,22,"No","End of Study","No","Per SCHARP administrative hold on product administration","No","No","Yes"
"HVTN 503","503-05050","Placebo","Yes","Female","Black","Soweto",NA,24,"No","End of Study","No","per SHARP administrative hold on product administration.","No","Yes","Yes"
"HVTN 503","503-14718","Vaccine","Yes","Female","Black","Soweto",NA,29,"No","End of Study","No","per SCHARP administrative hold on product administration","No","Yes","Yes"
"HVTN 503","503-14747","Placebo","Yes","Female","Black","Soweto",NA,30,"Yes","Refused Further Participation","No","Unable to schedule","No","Yes","Yes"
"HVTN 503","503-02969","Placebo","Yes","Female","Black","Soweto",NA,19,"Yes","Unable to Contact Participant","No","per scharp administrative hold on product administration","No","Yes","No"
"HVTN 503","503-08255","Vaccine","Yes","Female","Black","Soweto",NA,19,"No","End of Study","No","per scharp amdinistrative hold on product administration","No","Yes","Yes"
"HVTN 503","503-00784","Placebo","Yes","Female","Black","Soweto",NA,25,"No","End of Study","No","per scharp administrative hold on product administration","No","Yes","No"
"HVTN 503","503-00781","Vaccine","Yes","Female","Black","Soweto",NA,20,"No","End of Study","No","per SCHARP administrative hold on product administration","No","Yes","No"
"HVTN 503","503-10248","Placebo","Yes","Female","Black","Soweto",NA,25,"No","End of Study","No","per scharp administrative hold on product administration","No","Yes","Yes"
"HVTN 503","503-13765","Placebo","Yes","Female","Black","Soweto",NA,23,"No","End of Study","No","per SCHARP administrative hod on product administration","No","Yes","Yes"
"HVTN 503","503-01665","Placebo","Yes","Female","Black","Soweto",NA,22,"No","End of Study","No","per SCHARP administrative hold on product administration","No","Yes","No"
"HVTN 503","503-10949","Vaccine","Yes","Female","Black","Soweto",NA,22,"Yes","Refused Further Participation","No","per scharp administrative hold on product administration","No","Yes","Yes"
"HVTN 503","503-04649","Placebo","Yes","Female","Black","Soweto",NA,31,"No","End of Study","No","hvtn 503 oversight committee decision.","No","Yes","Yes"
"HVTN 503","503-11441","Vaccine","Yes","Female","Black","Soweto",NA,28,"No","End of Study","No","Pregnancy","Yes","Yes","Yes"
"HVTN 503","503-01980","Placebo","Yes","Female","Black","Soweto",NA,19,"No","End of Study","No","HVTN503 oversight committee decision","No","No","No"
"HVTN 503","503-07971","Placebo","Yes","Female","Black","Soweto",NA,34,"No","End of Study","No","per SCHARP administrative hold on product administration","No","Yes","Yes"
"HVTN 503","503-00357","Vaccine","Yes","Female","Black","Soweto",NA,35,"Yes","Participant Relocated","No","relocation participant relocating to an area where there is","No","No","Yes"
"HVTN 503","503-10575","Vaccine","Yes","Female","Black","Soweto",NA,20,"Yes","Other","No","hvtn 503 oversight committee decision","Yes","Yes","No"
"HVTN 503","503-01973","Placebo","Yes","Female","Black","Soweto",NA,34,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-13803","Vaccine","Yes","Female","Black","Soweto",NA,23,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-12890","Placebo","Yes","Female","Black","Soweto",NA,29,"No","End of Study","No","Unable to schedule","No","Yes","No"
"HVTN 503","503-08286","Placebo","Yes","Female","Black","Soweto",NA,19,"No","End of Study","No","HVTN 503 oversight committe decision","No","Yes","No"
"HVTN 503","503-00208","Vaccine","Yes","Female","Black","Soweto",NA,20,"Yes","Refused Further Participation","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-09508","Placebo","Yes","Female","Black","Soweto",NA,22,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-04329","Vaccine","Yes","Female","Black","Soweto",NA,19,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-09108","Vaccine","Yes","Female","Black","Soweto",NA,20,"No","End of Study","No","hvtn 503 oversight comittee decision.","No","Yes","Yes"
"HVTN 503","503-10413","Vaccine","Yes","Female","Black","Soweto",NA,24,"No","End of Study","No","hvtn 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-10348","Placebo","Yes","Female","Black","Soweto",NA,18,"No","End of Study","No","per SCHARP administrative hold on product administration","No","Yes","No"
"HVTN 503","503-10230","Vaccine","Yes","Female","Black","Soweto",NA,20,"No","End of Study","No","HVTN SO3 oversight committe decision","Yes","Yes","Yes"
"HVTN 503","503-12566","Placebo","Yes","Female","Black","Soweto",NA,25,"No","End of Study","No","HVTN 503 oversight committe decision","No","Yes","No"
"HVTN 503","503-00854","Vaccine","Yes","Female","Black","Soweto",NA,19,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-10507","Vaccine","Yes","Female","Black","Soweto",NA,22,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-07136","Placebo","Yes","Female","Black","Soweto",NA,24,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-12806","Vaccine","Yes","Female","Black","Soweto",NA,27,"No","End of Study","No","HVTN 503 oversight committee decision","Yes","Yes","Yes"
"HVTN 503","503-12109","Placebo","Yes","Female","Black","Soweto",NA,18,"Yes","Other","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-05780","Placebo","Yes","Female","Black","Soweto",NA,33,"Yes","Other","No","HVTN oversight committee decision","Yes","No","Yes"
"HVTN 503","503-09414","Placebo","Yes","Female","Black","Soweto",NA,21,"Yes","Other","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-09936","Vaccine","Yes","Female","Black","Soweto",NA,34,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-10988","Vaccine","Yes","Female","Black","Soweto",NA,30,"No","End of Study","No","HVTN 503 oversight committee decision","Yes","Yes","Yes"
"HVTN 503","503-12868","Placebo","Yes","Female","Black","Soweto",NA,18,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-08322","Placebo","Yes","Female","Black","Soweto",NA,34,"No","End of Study","No","""HVTN 503 oversight committee decision""","No","Yes","Yes"
"HVTN 503","503-05862","Placebo","Yes","Female","Black","Soweto",NA,18,"No","End of Study","No","DSMB recommendation","No","Yes","Yes"
"HVTN 503","503-07518","Vaccine","Yes","Female","Black","Soweto",NA,20,"No","End of Study","No","""HVTN 503 oversight commitee decision""","Yes","Yes","No"
"HVTN 503","503-07375","Placebo","Yes","Female","Black","Soweto",NA,18,"No","End of Study","No","DSMB recommendation","No","Yes","Yes"
"HVTN 503","503-09589","Vaccine","Yes","Female","Black","Soweto",NA,30,"No","End of Study","No","hvtn 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-03174","Placebo","Yes","Female","Black","Soweto",NA,18,"No","End of Study","No","Unable to contact","No","Yes","No"
"HVTN 503","503-09012","Vaccine","Yes","Female","Black","Soweto",NA,31,"No","End of Study","No","hvtn 503 oversight committee decision","Yes","Yes","Yes"
"HVTN 503","503-05055","Vaccine","Yes","Female","Black","Soweto",NA,28,"No","End of Study","No","HVTN 503 Oversight Committee decision.","No","Yes","No"
"HVTN 503","503-11622","Vaccine","Yes","Female","Black","Soweto",NA,28,"No","End of Study","No","HVTN503 oversight committee decision","Yes","Yes","Yes"
"HVTN 503","503-13210","Placebo","Yes","Female","Black","Soweto",NA,28,"No","End of Study","No","HVTN 503 oversite committee decision","No","Yes","No"
"HVTN 503","503-07223","Placebo","Yes","Female","Black","Soweto",NA,23,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-11686","Vaccine","Yes","Female","Black","Soweto",NA,23,"No","End of Study","No","HVTN503 oversight committee decision","Yes","Yes","Yes"
"HVTN 503","503-14440","Placebo","Yes","Female","Black","Soweto",NA,22,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-09907","Placebo","Yes","Female","Black","Soweto",NA,32,"No","End of Study","No","HVTN503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-00408","Vaccine","Yes","Female","Black","Soweto",NA,24,"No","End of Study","No","HVTN 503 oversight committee decision.","No","Yes","No"
"HVTN 503","503-01484","Vaccine","Yes","Female","Black","Soweto",NA,25,"Yes","Participant Relocated","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-07723","Placebo","Yes","Female","Black","Soweto",NA,19,"No","End of Study","No","HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-15546","Vaccine","Yes","Female","Black","Soweto",NA,29,"Yes","Other","No","per protocol amendment","Yes","No","Yes"
"HVTN 503","503-06095","Placebo","Yes","Female","Black","Soweto",NA,34,"No","End of Study","No","HVTN503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-02949","Vaccine","Yes","Female","Black","Soweto",NA,20,"No","End of Study","No","hvtn 503 oversight committee decsion","No","Yes","No"
"HVTN 503","503-07653","Vaccine","Yes","Female","Black","Soweto",NA,23,"Yes","Unable to Contact Participant","No","per scharp administrative hold on product administration","No","Yes","Yes"
"HVTN 503","503-09127","Vaccine","Yes","Female","Black","Soweto",NA,30,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-09752","Vaccine","Yes","Female","Black","Soweto",NA,33,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-04476","Placebo","Yes","Female","Black","Soweto",NA,24,"No","End of Study","No","DSMB recommendation","No","Yes","Yes"
"HVTN 503","503-10726","Placebo","Yes","Female","Black","Soweto",NA,23,"No","End of Study","No","Per ""HVTN 503 Oversight Committee decision"".","Yes","Yes","Yes"
"HVTN 503","503-11462","Placebo","Yes","Female","Black","Soweto",NA,30,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-00256","Placebo","Yes","Female","Black","Soweto",NA,31,"No","End of Study","No","unblinding","No","No","Yes"
"HVTN 503","503-03819","Placebo","Yes","Female","Black","Soweto",NA,20,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-12145","Vaccine","Yes","Female","Black","Soweto",NA,22,"No","End of Study","No","""hvtn 503 oversight committee decision""","No","Yes","Yes"
"HVTN 503","503-13815","Vaccine","Yes","Female","Black","Soweto",NA,28,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-10540","Vaccine","Yes","Female","Black","Soweto",NA,30,"No","End of Study","No","HVTN503 oversight committee decision","No","No","Yes"
"HVTN 503","503-15230","Vaccine","Yes","Female","Black","Soweto",NA,23,"Yes","Participant Relocated","No","HVTN 503 oversight committee decision","Yes","Yes","No"
"HVTN 503","503-12869","Vaccine","Yes","Female","Black","Soweto",NA,27,"Yes","Refused Further Participation","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-15592","Placebo","Yes","Female","Black","Soweto",NA,25,"No","End of Study","No","HTVN 503 oversight commitee decision","No","Yes","No"
"HVTN 503","503-05354","Placebo","Yes","Female","Black","Soweto",NA,20,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-06750","Vaccine","Yes","Female","Black","Soweto",NA,31,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-09289","Placebo","Yes","Female","Black","Soweto",NA,33,"No","End of Study","No","per SCHARP administrative hold on product administration","Yes","Yes","Yes"
"HVTN 503","503-00839","Placebo","Yes","Female","Black","Soweto",NA,33,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-13503","Placebo","Yes","Female","Black","Soweto",NA,33,"Yes","Other","No","HVTN 503 oversight committee decision","Yes","No","Yes"
"HVTN 503","503-15608","Placebo","Yes","Female","Black","Soweto",NA,22,"No","End of Study","No","""HVTN 503 oversight committe decision""","No","Yes","No"
"HVTN 503","503-12633","Vaccine","Yes","Female","Black","Soweto",NA,24,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-13956","Vaccine","Yes","Female","Black","Soweto",NA,22,"No","End of Study","No","hvtn 503 oversight committee decision.","Yes","Yes","No"
"HVTN 503","503-03035","Placebo","Yes","Female","Black","Soweto",NA,34,"No","End of Study","No","per SCHARP administrative hold on product administration","No","Yes","Yes"
"HVTN 503","503-07503","Placebo","Yes","Female","Black","Soweto",NA,27,"No","End of Study","No","as per SCHARP administrative hold on product administration","No","Yes","No"
"HVTN 503","503-06620","Vaccine","Yes","Female","Black","Soweto",NA,25,"No","End of Study","No","hvtn 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-04225","Placebo","Yes","Female","Black","Soweto",NA,19,"No","End of Study","No","per SCHARP administrative hold on product administration","No","Yes","Yes"
"HVTN 503","503-00327","Placebo","Yes","Female","Black","Soweto",NA,18,"No","End of Study","No","Per SCHARP administrative hold on product administration.","No","Yes","No"
"HVTN 503","503-03560","Placebo","Yes","Female","Black","Soweto",NA,19,"No","End of Study","No","per SCHARP administrative hold on product administration","No","Yes","No"
"HVTN 503","503-15703","Vaccine","Yes","Female","Black","Soweto",NA,22,"No","End of Study","No","per SCHARP administrative hold on product administration","No","Yes","Yes"
"HVTN 503","503-00238","Placebo","Yes","Female","Black","Soweto",NA,21,"No","End of Study","No","""HVTN 503 oversight committee decision""","Yes","Yes","No"
"HVTN 503","503-13715","Vaccine","Yes","Female","Black","Soweto",NA,18,"No","End of Study","No","per SCHARP administrative hold on product administration","No","Yes","Yes"
"HVTN 503","503-09608","Vaccine","Yes","Female","Black","Soweto",NA,18,"No","End of Study","No","per SCHARP administrative hold on product administration","Yes","Yes","Yes"
"HVTN 503","503-15667","Placebo","Yes","Female","Black","Soweto",NA,30,"No","End of Study","No","hvtn 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-06839","Vaccine","Yes","Female","Black","Soweto",NA,24,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-08562","Vaccine","Yes","Female","Black","Soweto",NA,22,"Yes","Death","Yes","per SCHARP administrative hold on product administration","No","Yes","No"
"HVTN 503","503-12345","Placebo","Yes","Female","Black","Soweto",NA,28,"No","End of Study","No","hvtn 503 oversight committee decision","No","No","No"
"HVTN 503","503-00507","Placebo","Yes","Female","Black","Soweto",NA,18,"No","End of Study","No","per SCHARP administrative hold on product administration","No","Yes","Yes"
"HVTN 503","503-02909","Placebo","Yes","Female","Black","Soweto",NA,32,"No","End of Study","No","per SCHARP administrative hold on product administration","No","Yes","Yes"
"HVTN 503","503-04782","Vaccine","Yes","Female","Black","Soweto",NA,19,"No","End of Study","No","per scharp administrative hold on product administration","No","Yes","No"
"HVTN 503","503-08724","Vaccine","Yes","Female","Black","Soweto",NA,18,"No","End of Study","No","per SCHARP administrative hold on product administration","No","No","No"
"HVTN 503","503-05677","Placebo","Yes","Female","Black","Soweto",NA,21,"Yes","Other","No","per Scharp administrative hold on product administration","Yes","Yes","Yes"
"HVTN 503","503-01534","Vaccine","Yes","Female","Black","Soweto",NA,18,"No","End of Study","No","per SCHARP administrative hold on product administration","No","Yes","Yes"
"HVTN 503","503-03011","Vaccine","Yes","Female","Black","Soweto",NA,21,"No","End of Study","No","per SCHARP administrative hold on product administration","Yes","Yes","No"
"HVTN 503","503-02240","Placebo","Yes","Female","Black","Soweto",NA,22,"No","End of Study","No","per scharp administrative hold on product administration","No","Yes","No"
"HVTN 503","503-00413","Vaccine","Yes","Female","Black","Soweto",NA,23,"No","End of Study","No","per scharp administrative hold on product administration","Yes","Yes","No"
"HVTN 503","503-00119","Vaccine","Yes","Female","Black","Soweto",NA,20,"No","End of Study","No","per SCHARP administrative hold on product administration","No","Yes","No"
"HVTN 503","503-12589","Vaccine","Yes","Female","Black","Soweto",NA,31,"No","End of Study","No","per SCHARP administrative hold on product administration","No","No","Yes"
"HVTN 503","503-10553","Placebo","Yes","Female","Black","Soweto",NA,21,"No","End of Study","No","Per SCHARP administrative hold on product administration","No","Yes","Yes"
"HVTN 503","503-03170","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",19,"No","End of Study","No","","No","No","No"
"HVTN 503","503-13966","Placebo","Yes","Male","Black","Soweto","circumcised on study",20,"No","End of Study","No","","No","Yes","No"
"HVTN 503","503-13124","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",23,"Yes","Unable to Contact Participant","No","","No","No","No"
"HVTN 503","503-00697","Placebo","Yes","Male","Black","Soweto","circumcised on study",23,"No","End of Study","No","","No","Yes","No"
"HVTN 503","503-02300","Placebo","Yes","Male","Black","Soweto","circumcised on study",19,"No","End of Study","No","","No","Yes","No"
"HVTN 503","503-13727","Vaccine","Yes","Male","Black","Soweto","circumcised at baseline",24,"No","End of Study","No","","No","Yes","No"
"HVTN 503","503-12394","Placebo","Yes","Male","Black","Soweto","circumcised at baseline",34,"No","End of Study","No","","No","Yes","No"
"HVTN 503","503-06411","Vaccine","Yes","Male","Black","Soweto","circumcised on study",21,"No","End of Study","No","","No","No","No"
"HVTN 503","503-11055","Placebo","Yes","Male","Black","Soweto","circumcised at baseline",27,"No","End of Study","No","","No","Yes","No"
"HVTN 503","503-02865","Vaccine","Yes","Male","Black","Soweto","circumcised at baseline",28,"No","End of Study","No","","No","Yes","No"
"HVTN 503","503-02219","Placebo","Yes","Male","Black","Soweto","circumcised at baseline",22,"No","End of Study","No","per SCHARP administrative hold on product administration","No","Yes","No"
"HVTN 503","503-08025","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",22,"No","End of Study","No","","No","Yes","No"
"HVTN 503","503-05174","Vaccine","Yes","Male","Black","Soweto","circumcised on study",21,"No","End of Study","No","","No","Yes","No"
"HVTN 503","503-04266","Placebo","Yes","Male","Black","Soweto","uncircumcised throughout the study",19,"Yes","Participant Relocated","No","","No","Yes","No"
"HVTN 503","503-14033","Placebo","Yes","Male","Black","Soweto","circumcised at baseline",21,"Yes","Unable to Contact Participant","No","","No","Yes","No"
"HVTN 503","503-13608","Placebo","Yes","Male","Black","Soweto","circumcised on study",25,"No","End of Study","No","","No","Yes","No"
"HVTN 503","503-10400","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",20,"No","End of Study","No","","No","Yes","No"
"HVTN 503","503-06081","Vaccine","Yes","Male","Black","Soweto","circumcised on study",26,"No","End of Study","No","","No","Yes","No"
"HVTN 503","503-12234","Placebo","Yes","Male","Black","Soweto","circumcised on study",23,"Yes","Participant Relocated","No","participant missed visit 07.0 no reason","No","Yes","No"
"HVTN 503","503-07022","Placebo","Yes","Male","Black","Soweto","circumcised on study",26,"No","End of Study","No","per scharp administrative hold on product administration","No","Yes","No"
"HVTN 503","503-09209","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",19,"No","End of Study","No","per scharp administrative hold on product administration","No","Yes","No"
"HVTN 503","503-00055","Placebo","Yes","Male","Black","Soweto","circumcised at baseline",32,"No","End of Study","No","per scharp administrative hold on product administration","No","Yes","Yes"
"HVTN 503","503-14916","Vaccine","Yes","Male","Black","Soweto","circumcised on study",23,"No","End of Study","No","per SCHARP administrative hold on product administration","No","Yes","No"
"HVTN 503","503-01176","Placebo","Yes","Male","Black","Soweto","uncircumcised throughout the study",27,"No","End of Study","No","per SCHARP administrative hold on product administration","No","No","No"
"HVTN 503","503-14315","Vaccine","Yes","Male","Black","Soweto","circumcised on study",24,"No","End of Study","No","per SCHARP administrative hold on product administration","No","No","No"
"HVTN 503","503-00997","Placebo","Yes","Male","Black","Soweto","uncircumcised throughout the study",23,"No","End of Study","No","per SCHARP administrative hold on product administration","No","Yes","No"
"HVTN 503","503-05455","Vaccine","Yes","Male","Black","Soweto","circumcised on study",24,"No","End of Study","No","per SCHARP administrative hold on product administration","No","Yes","No"
"HVTN 503","503-04707","Vaccine","Yes","Male","Black","Soweto","circumcised on study",29,"Yes","Other","No","per SCHARP administrative hold on product administration.","No","No","No"
"HVTN 503","503-09774","Vaccine","Yes","Male","Black","Soweto","circumcised on study",21,"No","End of Study","No","DSMB recommendong","No","No","No"
"HVTN 503","503-08115","Vaccine","Yes","Male","Black","Soweto","circumcised at baseline",21,"Yes","Participant Relocated","No","HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-02448","Vaccine","Yes","Male","Black","Soweto","circumcised at baseline",21,"No","End of Study","No","per HVTN 503 overall committee decision","No","Yes","No"
"HVTN 503","503-08472","Placebo","Yes","Male","Black","Soweto","circumcised at baseline",25,"No","End of Study","No","oversight committee decision","No","No","No"
"HVTN 503","503-13152","Vaccine","Yes","Male","Black","Soweto","circumcised on study",28,"No","End of Study","No","HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-08252","Vaccine","Yes","Male","Black","Soweto","circumcised at baseline",30,"Yes","Other","No","HVTN 503 oversight committee decision","Yes","Yes","Yes"
"HVTN 503","503-11125","Vaccine","Yes","Male","Black","Soweto","circumcised at baseline",27,"No","End of Study","No","HVTN 503 oversight committee decision","No","No","Yes"
"HVTN 503","503-07525","Placebo","Yes","Male","Black","Soweto","circumcised on study",28,"No","End of Study","No","HVTN 503 oversight committe decision","No","Yes","No"
"HVTN 503","503-13266","Placebo","Yes","Male","Black","Soweto","circumcised at baseline",25,"No","End of Study","No","DSMB decision","No","No","No"
"HVTN 503","503-13280","Placebo","Yes","Male","Black","Soweto","uncircumcised throughout the study",22,"No","End of Study","No","Unable to schedule","No","Yes","No"
"HVTN 503","503-09135","Placebo","Yes","Male","Black","Soweto","circumcised on study",30,"No","End of Study","No","HVTN 503 oversight committe decision","No","No","No"
"HVTN 503","503-15550","Vaccine","Yes","Male","Black","Soweto","circumcised on study",23,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-02155","Vaccine","Yes","Male","Black","Soweto","uncircumcised at baseline and no follow-up circumcision assessment",32,"Yes","Death","Yes","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-08091","Placebo","Yes","Male","Black","Soweto","circumcised at baseline",22,"No","End of Study","No","hvtn 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-00658","Vaccine","Yes","Male","Black","Soweto","circumcised at baseline",20,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-14684","Placebo","Yes","Male","Black","Soweto","uncircumcised throughout the study",21,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-11719","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",26,"No","End of Study","No","HVTN 503 oversight committee decision","No","No","Yes"
"HVTN 503","503-04734","Vaccine","Yes","Male","Black","Soweto","circumcised at baseline",19,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-11297","Vaccine","Yes","Male","Black","Soweto","circumcised on study",23,"No","End of Study","No","hvtn 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-03361","Placebo","Yes","Male","Black","Soweto","circumcised at baseline",28,"Yes","Refused Further Participation","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-02100","Placebo","Yes","Male","Black","Soweto","circumcised at baseline",19,"No","End of Study","No","hvtn 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-07359","Placebo","Yes","Male","Black","Soweto","uncircumcised throughout the study",21,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-15995","Placebo","Yes","Male","Black","Soweto","circumcised at baseline",19,"Yes","Participant Relocated","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-09701","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",23,"No","End of Study","No","HVTN 503 oversight comittee decision","No","Yes","No"
"HVTN 503","503-01918","Vaccine","Yes","Male","Black","Soweto","circumcised on study",18,"No","End of Study","No","HVTN 503 oversight committee decision","Yes","Yes","Yes"
"HVTN 503","503-15457","Vaccine","Yes","Male","Black","Soweto","circumcised at baseline",20,"Yes","Refused Further Participation","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-14978","Placebo","Yes","Male","Black","Soweto","circumcised on study",23,"No","End of Study","No","hvtn 503 oversight committee decison.","No","Yes","No"
"HVTN 503","503-14064","Vaccine","Yes","Male","Black","Soweto","circumcised on study",19,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-07317","Placebo","Yes","Male","Black","Soweto","circumcised on study",19,"No","End of Study","No","HVTN 502 oversight committee decision","No","Yes","No"
"HVTN 503","503-14771","Placebo","Yes","Male","Black","Soweto","circumcised on study",19,"Yes","Participant Relocated","No","unblinding HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-12968","Placebo","Yes","Male","Black","Soweto","circumcised on study",27,"No","End of Study","No","HVTN 503 oversight committe decision","No","Yes","No"
"HVTN 503","503-01057","Vaccine","Yes","Male","Black","Soweto","circumcised on study",21,"No","End of Study","No","hvtn 503 oversight committee decision","No","No","No"
"HVTN 503","503-04676","Placebo","Yes","Male","Black","Soweto","circumcised on study",20,"No","End of Study","No","DSMB recommendation","No","Yes","No"
"HVTN 503","503-09008","Vaccine","Yes","Male","Black","Soweto","circumcised at baseline",20,"No","End of Study","No","DSMB recommendation","Yes","Yes","No"
"HVTN 503","503-06661","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",26,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-02783","Vaccine","Yes","Male","Black","Soweto","circumcised at baseline",32,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-07179","Vaccine","Yes","Male","Black","Soweto","circumcised on study",28,"Yes","Participant Relocated","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-12820","Vaccine","Yes","Male","Black","Soweto","circumcised at baseline",24,"No","End of Study","No","per scharp administrative hold product administration","No","Yes","No"
"HVTN 503","503-13936","Placebo","Yes","Male","Black","Soweto","uncircumcised throughout the study",19,"No","End of Study","No","""HVTN 503 oversight committee decision""","No","Yes","No"
"HVTN 503","503-13640","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",21,"No","End of Study","No","HVTN503 oversight committee decision","No","Yes","No"
"HVTN 503","503-11388","Placebo","Yes","Male","Black","Soweto","uncircumcised throughout the study",20,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-13203","Placebo","Yes","Male","Black","Soweto","circumcised on study",20,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-01075","Placebo","Yes","Male","Black","Soweto","uncircumcised throughout the study",18,"No","End of Study","No","HVTN 503 oversight committee dicision","No","No","No"
"HVTN 503","503-02084","Placebo","Yes","Male","Black","Soweto","uncircumcised throughout the study",19,"No","End of Study","No","hvtn 503 oversight committee decison","No","Yes","No"
"HVTN 503","503-06149","Vaccine","Yes","Male","Black","Soweto","circumcised on study",18,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-01865","Vaccine","Yes","Male","Black","Soweto","circumcised on study",18,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-03061","Placebo","Yes","Male","Black","Soweto","uncircumcised throughout the study",18,"Yes","Participant Relocated","No","HVTN 503 oversight committee decision. and participant reloc","No","No","No"
"HVTN 503","503-08369","Vaccine","Yes","Male","Black","Soweto","circumcised at baseline",19,"No","End of Study","No","HVTN 503 oversite committee decision","No","Yes","No"
"HVTN 503","503-07773","Placebo","Yes","Male","Black","Soweto","circumcised on study",20,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-04813","Placebo","Yes","Male","Black","Soweto","circumcised at baseline",20,"No","End of Study","No","HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-05923","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",19,"Yes","Participant Relocated","No","per scharp administrative hold product administration","No","No","No"
"HVTN 503","503-00668","Vaccine","Yes","Male","Black","Soweto","circumcised at baseline",21,"No","End of Study","No","HVTN 503 oversight committe decision","No","Yes","No"
"HVTN 503","503-12187","Placebo","Yes","Male","Black","Soweto","circumcised on study",26,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-01578","Placebo","Yes","Male","Black","Soweto","uncircumcised throughout the study",20,"No","End of Study","No","""HVTN 503 oversight committee decision""","No","No","No"
"HVTN 503","503-13265","Vaccine","Yes","Male","Black","Soweto","circumcised at baseline",19,"No","End of Study","No","hvtn 503 oversight committee decsion","No","Yes","No"
"HVTN 503","503-03165","Placebo","Yes","Male","Black","Soweto","circumcised on study",23,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-14529","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",18,"No","End of Study","No","HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-04014","Placebo","Yes","Male","Black","Soweto","uncircumcised throughout the study",18,"Yes","Unable to Contact Participant","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-14102","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",21,"Yes","Refused Further Participation","No","hvtn503 oversight committe decision","Yes","Yes","No"
"HVTN 503","503-03315","Placebo","Yes","Male","Black","Soweto","circumcised at baseline",22,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-14489","Vaccine","Yes","Male","Black","Soweto","circumcised on study",20,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-07235","Placebo","Yes","Male","Black","Soweto","circumcised on study",21,"No","End of Study","No","HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-13935","Placebo","Yes","Male","Black","Soweto","circumcised on study",19,"No","End of Study","No","hvtn 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-14040","Placebo","Yes","Male","Black","Soweto","circumcised on study",18,"No","End of Study","No","hvtn 503 oversight committee decsion","No","Yes","No"
"HVTN 503","503-04602","Placebo","Yes","Male","Black","Soweto","circumcised on study",21,"No","End of Study","No","HVTN 503 oversight committe decision","No","Yes","No"
"HVTN 503","503-06960","Placebo","Yes","Male","Black","Soweto","circumcised on study",22,"No","End of Study","No","HVNT 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-01670","Placebo","Yes","Male","Black","Soweto","circumcised on study",23,"No","End of Study","No","HVTN503 Oversight Committee decision","No","Yes","No"
"HVTN 503","503-10353","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",20,"No","End of Study","No","""hvtn 503 oversight committee decision""","No","Yes","No"
"HVTN 503","503-12063","Placebo","Yes","Male","Black","Soweto","uncircumcised throughout the study",20,"Yes","Other","No","HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-01093","Vaccine","Yes","Male","Black","Soweto","circumcised on study",20,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-10071","Placebo","Yes","Male","Black","Soweto","uncircumcised throughout the study",21,"Yes","Other","No","HVTN 503 oversight committee decision","Yes","Yes","Yes"
"HVTN 503","503-14456","Placebo","Yes","Male","Black","Soweto","circumcised on study",18,"No","End of Study","No","""HVTN 503 oversight committee decision""","No","Yes","No"
"HVTN 503","503-15707","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",21,"No","End of Study","No","HVTN 503 oversight commitee decision","No","Yes","No"
"HVTN 503","503-00114","Vaccine","Yes","Male","Black","Soweto","circumcised on study",18,"No","End of Study","No","HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-11841","Placebo","Yes","Male","Black","Soweto","uncircumcised throughout the study",19,"No","End of Study","No","""HVTN 503 oversight committee decision""","No","Yes","No"
"HVTN 503","503-12723","Vaccine","Yes","Male","Black","Soweto","circumcised on study",18,"No","End of Study","No","HVTN oversight committee decision","No","Yes","No"
"HVTN 503","503-11118","Placebo","Yes","Male","Black","Soweto","circumcised at baseline",18,"No","End of Study","No","hvtn503 oversight committee decison","No","No","No"
"HVTN 503","503-15467","Placebo","Yes","Male","Black","Soweto","circumcised on study",21,"No","End of Study","No","HVTN 503 oversight committe decision","No","No","No"
"HVTN 503","503-07658","Placebo","Yes","Male","Black","Soweto","circumcised on study",19,"No","End of Study","No","HVTN 503 oversight committe decision","No","Yes","No"
"HVTN 503","503-03267","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",34,"No","End of Study","No","unblinding","No","Yes","No"
"HVTN 503","503-11639","Vaccine","Yes","Male","Black","Soweto","circumcised on study",24,"No","End of Study","No","HVTN 503 oversight committe decision","No","Yes","No"
"HVTN 503","503-09703","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",20,"Yes","Unable to Contact Participant","No","HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-07024","Placebo","Yes","Male","Black","Soweto","circumcised at baseline",18,"No","End of Study","No","per HVTN 503 external committee decision","No","Yes","No"
"HVTN 503","503-08035","Vaccine","Yes","Male","Black","Soweto","circumcised at baseline",21,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-06287","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",19,"No","End of Study","No","hvtn 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-02415","Placebo","Yes","Male","Black","Soweto","circumcised at baseline",19,"No","End of Study","No","HVTN 503 oversight committe decision","No","Yes","No"
"HVTN 503","503-14065","Vaccine","Yes","Male","Black","Soweto","circumcised on study",25,"No","End of Study","No","""HVTN 503 oversight committee decision""","No","Yes","No"
"HVTN 503","503-02832","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",21,"Yes","Refused Further Participation","No","hvtn 503 oversight committee decision.","No","No","No"
"HVTN 503","503-12923","Vaccine","Yes","Male","Black","Soweto","circumcised on study",18,"No","End of Study","No","hvtn 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-08428","Placebo","Yes","Male","Black","Soweto","circumcised at baseline",34,"No","End of Study","No","HVTN 503 oversight committe decision","No","Yes","Yes"
"HVTN 503","503-12304","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",19,"Yes","Unable to Contact Participant","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-06715","Placebo","Yes","Male","Black","Soweto","circumcised at baseline",20,"Yes","Unable to Contact Participant","No","per scharp administrative hold product administration","No","Yes","No"
"HVTN 503","503-07697","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",20,"Yes","Other","No","per scharp administrative hold product administration","No","Yes","No"
"HVTN 503","503-02817","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",20,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-02168","Placebo","Yes","Male","Black","Soweto","circumcised at baseline",32,"No","End of Study","No","hvtn503 oversight committee decision","No","Yes","No"
"HVTN 503","503-01930","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",27,"Yes","Unable to Contact Participant","No","hvtn 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-06453","Vaccine","Yes","Male","Black","Soweto","circumcised at baseline",24,"Yes","Other","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-05990","Placebo","Yes","Male","Black","Soweto","circumcised on study",21,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-12465","Vaccine","Yes","Male","Black","Soweto","circumcised on study",22,"No","End of Study","No","HVTN oversight committee decision","No","Yes","No"
"HVTN 503","503-06080","Placebo","Yes","Male","Black","Soweto","circumcised at baseline",22,"No","End of Study","No","HVTN SO3 oversight committee decision","No","Yes","No"
"HVTN 503","503-10853","Placebo","Yes","Male","Black","Soweto","circumcised on study",24,"No","End of Study","No","HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-10467","Placebo","Yes","Male","Black","Soweto","circumcised at baseline",20,"Yes","Unable to Contact Participant","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-14197","Placebo","Yes","Male","Other","Soweto","circumcised on study",34,"No","End of Study","No","per scharp administrative hold on product administration","Yes","Yes","Yes"
"HVTN 503","503-12203","Placebo","Yes","Male","Black","Soweto","circumcised at baseline",22,"No","End of Study","No","""HVTN 503 oversight committee decision""","No","Yes","No"
"HVTN 503","503-15461","Vaccine","Yes","Male","Black","Soweto","circumcised on study",19,"No","End of Study","No","HVTN 503 oversight committe decision","No","Yes","No"
"HVTN 503","503-10557","Placebo","Yes","Male","Black","Soweto","uncircumcised throughout the study",20,"No","End of Study","No","HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-13150","Vaccine","Yes","Male","Black","Soweto","circumcised on study",30,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-15436","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",22,"Yes","Participant Relocated","No","per SCHARP administrative hold on product administration","Yes","Yes","No"
"HVTN 503","503-08053","Placebo","Yes","Male","Black","Soweto","circumcised at baseline",20,"Yes","Unable to Contact Participant","No","per SCHARP administrative hold on product administration","No","Yes","No"
"HVTN 503","503-01804","Vaccine","Yes","Male","Black","Soweto","circumcised on study",19,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-14757","Vaccine","Yes","Male","Black","Soweto","circumcised on study",20,"No","End of Study","No","per scharp administrative hold on product administration","No","No","No"
"HVTN 503","503-06361","Placebo","Yes","Male","Black","Soweto","circumcised at baseline",25,"No","End of Study","No","per SCHARP administrative hold on product administration","No","Yes","No"
"HVTN 503","503-15095","Placebo","Yes","Male","Black","Soweto","circumcised on study",19,"No","End of Study","No","per SCHARP administrative hold on product administration","No","Yes","No"
"HVTN 503","503-03508","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",35,"Yes","Other","No","per SCHARP administrative hold on product administration","No","No","Yes"
"HVTN 503","503-04769","Vaccine","Yes","Male","Black","Soweto","circumcised on study",29,"No","End of Study","No","Per SCHARP administrative hold on product administration","No","Yes","No"
"HVTN 503","503-07828","Vaccine","Yes","Male","Black","Soweto","circumcised on study",25,"Yes","Participant Relocated","No","per scharp administrative hold on product administration","Yes","No","Yes"
"HVTN 503","503-14485","Placebo","Yes","Male","Black","Soweto","uncircumcised throughout the study",27,"Yes","Other","No","per SCHARP administrative hold on product administration","No","Yes","Yes"
"HVTN 503","503-12445","Vaccine","Yes","Male","Black","Soweto","circumcised at baseline",26,"No","End of Study","No","Per SCHARP administrative hold on product administration","No","No","No"
"HVTN 503","503-00484","Vaccine","Yes","Male","Black","Soweto","circumcised on study",18,"No","End of Study","No","Per SCHARP administrative hold on product administration","No","Yes","No"
"HVTN 503","503-03713","Placebo","Yes","Male","Black","Soweto","circumcised on study",18,"No","End of Study","No","Per scharp administrative hold on product administration","No","Yes","No"
"HVTN 503","503-12742","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",18,"No","End of Study","No","hvtn 503 oversight commitee decision","No","Yes","No"
"HVTN 503","503-05979","Placebo","Yes","Male","Black","Soweto","uncircumcised throughout the study",22,"No","End of Study","No","HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-09147","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",18,"No","End of Study","No","Per SCHARP administrative hold on product administration","Yes","No","Yes"
"HVTN 503","503-13772","Vaccine","Yes","Male","Black","Soweto","circumcised on study",22,"No","End of Study","No","per SCHARP administrative hold on product administration","No","Yes","No"
"HVTN 503","503-03350","Placebo","Yes","Male","Black","Soweto","circumcised on study",19,"No","End of Study","No","per sharp administrative hold on product administration","No","Yes","No"
"HVTN 503","503-06395","Placebo","Yes","Male","Black","Soweto","circumcised on study",20,"Yes","Other","No","per SCHARP administrative hold on product administration","No","No","No"
"HVTN 503","503-01048","Placebo","Yes","Male","Black","Soweto","uncircumcised throughout the study",33,"No","End of Study","No","Per SCHARP administrative hold on product administration","No","Yes","Yes"
"HVTN 503","503-15731","Placebo","Yes","Male","Black","Soweto","circumcised at baseline",27,"No","End of Study","No","Per SCHARP administrative hold on product administration","No","Yes","No"
"HVTN 503","503-11476","Placebo","Yes","Male","Black","Soweto","circumcised at baseline",23,"No","End of Study","No","per SCHARP administrative hold on product administration","No","No","Yes"
"HVTN 503","503-02764","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",33,"No","End of Study","No","per SCHARP administrative hold on product administration","No","Yes","Yes"
"HVTN 503","503-15934","Placebo","Yes","Male","Black","Soweto","circumcised on study",32,"No","End of Study","No","per SCHARP - administrative hold on product administration","No","Yes","No"
"HVTN 503","503-02051","Vaccine","Yes","Male","Black","Soweto","uncircumcised throughout the study",21,"No","End of Study","No","per SCHARP administrative hold on product administration","Yes","Yes","No"
"HVTN 503","503-02668","Vaccine","Yes","Male","Black","Soweto","circumcised at baseline",22,"No","End of Study","No","Per SCHARP Administrative Hold on product administration","No","Yes","No"
"HVTN 503","503-15806","Placebo","Yes","Male","Black","Soweto","circumcised on study",21,"No","End of Study","No","Per SCHARP administrative hold on product administration","No","No","No"
"HVTN 503","503-10946","Vaccine","Yes","Male","Black","Soweto","circumcised on study",20,"No","End of Study","No","per SCHARP administrative hold on product administration","No","Yes","No"
"HVTN 503","503-00255","Vaccine","Yes","Female","Black","Cape Town",NA,26,"No","End of Study","No","","No","No","Yes"
"HVTN 503","503-07858","Vaccine","Yes","Female","Black","Cape Town",NA,26,"No","End of Study","No","","No","Yes","Yes"
"HVTN 503","503-15676","Placebo","Yes","Female","Black","Cape Town",NA,29,"No","End of Study","No","","No","Yes","Yes"
"HVTN 503","503-03818","Vaccine","Yes","Female","Black","Cape Town",NA,21,"No","End of Study","No","Unable to contact","No","Yes","Yes"
"HVTN 503","503-00485","Placebo","Yes","Female","Black","Cape Town",NA,32,"No","End of Study","No","","No","Yes","Yes"
"HVTN 503","503-13496","Vaccine","Yes","Female","Black","Cape Town",NA,34,"Yes","Unable to Contact Participant","No","","No","Yes","Yes"
"HVTN 503","503-01009","Vaccine","Yes","Female","Black","Cape Town",NA,25,"No","End of Study","No","HIV infection","Yes","Yes","Yes"
"HVTN 503","503-08705","Placebo","Yes","Female","Black","Cape Town",NA,32,"Yes","Death","Yes","","Yes","No","Yes"
"HVTN 503","503-01167","Placebo","Yes","Female","Black","Cape Town",NA,28,"No","End of Study","No","","No","Yes","No"
"HVTN 503","503-01838","Vaccine","Yes","Female","Black","Cape Town",NA,31,"No","End of Study","No","","No","Yes","Yes"
"HVTN 503","503-09830","Placebo","Yes","Female","Black","Cape Town",NA,23,"No","End of Study","No","per scharp- study administrative pause","No","Yes","Yes"
"HVTN 503","503-02660","Vaccine","Yes","Female","Black","Cape Town",NA,22,"No","End of Study","No","Pregnancy","Yes","Yes","Yes"
"HVTN 503","503-14303","Placebo","Yes","Female","Black","Cape Town",NA,24,"No","End of Study","No","","No","Yes","Yes"
"HVTN 503","503-13573","Placebo","Yes","Female","Black","Cape Town",NA,28,"No","End of Study","No","","No","Yes","Yes"
"HVTN 503","503-15968","Placebo","Yes","Female","Black","Cape Town",NA,22,"No","End of Study","No","Unable to schedule","No","Yes","Yes"
"HVTN 503","503-05730","Placebo","Yes","Female","Black","Cape Town",NA,19,"Yes","Refused Further Participation","No","per SCHARP - study administrative pause","Yes","Yes","Yes"
"HVTN 503","503-13282","Vaccine","Yes","Female","Black","Cape Town",NA,26,"No","End of Study","No","per scharp. administrative hold on product administration.","No","Yes","Yes"
"HVTN 503","503-09779","Vaccine","Yes","Female","Black","Cape Town",NA,27,"No","End of Study","No","per scharp- study administrative pause","No","Yes","Yes"
"HVTN 503","503-10485","Placebo","Yes","Female","Black","Cape Town",NA,30,"No","End of Study","No","as per SCHARP admin study pause","No","Yes","Yes"
"HVTN 503","503-12896","Placebo","Yes","Female","Black","Cape Town",NA,25,"Yes","Unable to Contact Participant","No","As per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-10597","Vaccine","Yes","Female","Black","Cape Town",NA,27,"No","End of Study","No","efficacy pause","No","Yes","Yes"
"HVTN 503","503-13456","Vaccine","Yes","Female","Black","Cape Town",NA,27,"No","End of Study","No","HVTN oversight committee decision","No","Yes","No"
"HVTN 503","503-06147","Vaccine","Yes","Female","Black","Cape Town",NA,26,"Yes","Unable to Contact Participant","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-09180","Vaccine","Yes","Female","Other","Cape Town",NA,24,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-02383","Placebo","Yes","Female","Black","Cape Town",NA,23,"No","End of Study","No","HVTN 503 Oversight Committee decision","Yes","Yes","Yes"
"HVTN 503","503-13948","Vaccine","Yes","Female","Black","Cape Town",NA,27,"No","End of Study","No","As per HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-05958","Placebo","Yes","Female","Black","Cape Town",NA,22,"Yes","Unable to Contact Participant","No","HVTN - 503 oversight committee decision","No","No","No"
"HVTN 503","503-00257","Placebo","Yes","Female","Black","Cape Town",NA,26,"No","End of Study","No","as per HVTN 503 committee decision","No","Yes","Yes"
"HVTN 503","503-13303","Vaccine","Yes","Female","Black","Cape Town",NA,26,"No","End of Study","No","HVTN 503 protocol oversight committee decision","No","Yes","Yes"
"HVTN 503","503-07913","Vaccine","Yes","Female","Black","Cape Town",NA,27,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-12121","Vaccine","Yes","Female","Black","Cape Town",NA,27,"No","End of Study","No","As per HVTN 503 oversight committee","Yes","Yes","No"
"HVTN 503","503-07896","Placebo","Yes","Female","Black","Cape Town",NA,28,"No","End of Study","No","HVTN 503 protocol oversight committee","No","Yes","No"
"HVTN 503","503-06622","Placebo","Yes","Female","Black","Cape Town",NA,31,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-08875","Placebo","Yes","Female","Black","Cape Town",NA,30,"Yes","Participant Relocated","No","HVTN 503 committee decision  protocol oversight","No","Yes","Yes"
"HVTN 503","503-02552","Placebo","Yes","Female","Black","Cape Town",NA,30,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-14054","Placebo","Yes","Female","Black","Cape Town",NA,29,"No","End of Study","No","HVTN503 oversight committee decision","No","No","Yes"
"HVTN 503","503-02733","Vaccine","Yes","Female","Black","Cape Town",NA,26,"No","End of Study","No","HVTN 503 protocol oversight committee decision","No","Yes","Yes"
"HVTN 503","503-13816","Vaccine","Yes","Female","Black","Cape Town",NA,27,"No","End of Study","No","HVTN 503 protocol oversight committee decision","No","Yes","Yes"
"HVTN 503","503-15473","Vaccine","Yes","Female","Black","Cape Town",NA,20,"No","End of Study","No","safety team decision after pause HVTN 503 protocol oversight","No","Yes","Yes"
"HVTN 503","503-03722","Placebo","Yes","Female","Black","Cape Town",NA,20,"No","End of Study","No","Unable to contact","Yes","Yes","Yes"
"HVTN 503","503-12617","Placebo","Yes","Female","Black","Cape Town",NA,31,"Yes","Refused Further Participation","No","unblinding: as per HVTN 503 protocol oversight committee","No","Yes","Yes"
"HVTN 503","503-13320","Placebo","Yes","Female","Black","Cape Town",NA,23,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-08609","Vaccine","Yes","Female","Other","Cape Town",NA,20,"Yes","Unable to Contact Participant","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-01163","Placebo","Yes","Female","Black","Cape Town",NA,31,"Yes","Refused Further Participation","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-12737","Vaccine","Yes","Female","Black","Cape Town",NA,18,"Yes","Participant Relocated","No","per HVTN 503 protocol oversight committee","No","Yes","No"
"HVTN 503","503-02672","Vaccine","Yes","Female","Black","Cape Town",NA,18,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-00698","Placebo","Yes","Female","Black","Cape Town",NA,21,"No","End of Study","No","hvtn 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-13550","Vaccine","Yes","Female","Black","Cape Town",NA,28,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-02854","Placebo","Yes","Female","Black","Cape Town",NA,26,"No","End of Study","No","HVTN 503 oversight committee","Yes","Yes","Yes"
"HVTN 503","503-07162","Vaccine","Yes","Female","Black","Cape Town",NA,20,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-14104","Vaccine","Yes","Female","Black","Cape Town",NA,20,"No","End of Study","No","HVTN 503 protocol oversight committee decision","No","Yes","Yes"
"HVTN 503","503-04985","Vaccine","Yes","Female","Black","Cape Town",NA,18,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-06150","Placebo","Yes","Female","Black","Cape Town",NA,26,"No","End of Study","No","HVTN 503 oversight committee decision","Yes","Yes","Yes"
"HVTN 503","503-00876","Vaccine","Yes","Female","Black","Cape Town",NA,19,"Yes","Unable to Contact Participant","No","admin pause","No","Yes","No"
"HVTN 503","503-02539","Placebo","Yes","Female","Black","Cape Town",NA,19,"No","End of Study","No","HVTN 503 oversight committee decision.","No","Yes","No"
"HVTN 503","503-06679","Vaccine","Yes","Female","Black","Cape Town",NA,20,"Yes","Unable to Contact Participant","No","as per HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-07001","Placebo","Yes","Female","Black","Cape Town",NA,23,"No","End of Study","No","HVTN 503 oversight committe decision","Yes","Yes","Yes"
"HVTN 503","503-11474","Vaccine","Yes","Female","Black","Cape Town",NA,21,"No","End of Study","No","HVTN 503 oversight committee decision","Yes","Yes","No"
"HVTN 503","503-04652","Vaccine","Yes","Female","Black","Cape Town",NA,30,"Yes","Unable to Contact Participant","No","As per SCHARP admin pause","No","No","Yes"
"HVTN 503","503-00740","Placebo","Yes","Female","Black","Cape Town",NA,30,"Yes","Unable to Contact Participant","No","Unable to schedule","No","Yes","Yes"
"HVTN 503","503-08197","Placebo","No","Female","Black","Cape Town",NA,24,"No","End of Study","No","Unable to schedule","Yes","Yes","Yes"
"HVTN 503","503-02935","Vaccine","Yes","Female","Black","Cape Town",NA,31,"No","End of Study","No","HVTN 503 unblinding committee decision.","No","Yes","No"
"HVTN 503","503-09177","Placebo","Yes","Female","Black","Cape Town",NA,29,"Yes","Unable to Contact Participant","No","hvtn 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-05831","Vaccine","Yes","Female","Black","Cape Town",NA,27,"Yes","Participant Relocated","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-14495","Placebo","Yes","Female","Black","Cape Town",NA,18,"Yes","Other","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-11413","Vaccine","Yes","Female","Black","Cape Town",NA,19,"No","End of Study","No","hvtn503 oversight committee decision","Yes","Yes","No"
"HVTN 503","503-02182","Vaccine","Yes","Female","Black","Cape Town",NA,21,"No","End of Study","No","HVTN 503 oversight committee decision","Yes","Yes","No"
"HVTN 503","503-15107","Placebo","Yes","Female","Black","Cape Town",NA,24,"Yes","Unable to Contact Participant","No","HVTN 503 oversight committee decision","No","No","Yes"
"HVTN 503","503-12123","Vaccine","Yes","Female","Black","Cape Town",NA,20,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-12395","Placebo","Yes","Female","Black","Cape Town",NA,21,"No","End of Study","No","per SCHARP - study administrative pause","No","Yes","Yes"
"HVTN 503","503-06990","Placebo","Yes","Female","Black","Cape Town",NA,18,"No","End of Study","No","hvtn 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-03887","Vaccine","Yes","Female","Black","Cape Town",NA,21,"No","End of Study","No","per SCHARP - study administrative hold/pause","No","Yes","Yes"
"HVTN 503","503-14043","Placebo","Yes","Female","Black","Cape Town",NA,19,"No","End of Study","No","HVTN 503 protocol oversight committee decision","No","No","No"
"HVTN 503","503-08656","Placebo","Yes","Female","Black","Cape Town",NA,31,"Yes","Unable to Contact Participant","No","HVTN 503 study oversight committee","No","Yes","No"
"HVTN 503","503-08445","Placebo","Yes","Female","Black","Cape Town",NA,28,"No","End of Study","No","Pregnancy","No","Yes","Yes"
"HVTN 503","503-06120","Vaccine","Yes","Female","Black","Cape Town",NA,23,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-05451","Vaccine","Yes","Female","Black","Cape Town",NA,21,"No","End of Study","No","as per HVTN 503 committee decision","No","Yes","No"
"HVTN 503","503-01408","Placebo","Yes","Female","Black","Cape Town",NA,34,"Yes","Refused Further Participation","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-11204","Vaccine","Yes","Female","Black","Cape Town",NA,21,"No","End of Study","No","HVTN 503 oversight committee decision","Yes","No","No"
"HVTN 503","503-15284","Vaccine","Yes","Female","Black","Cape Town",NA,24,"No","End of Study","No","Pregnancy","No","No","Yes"
"HVTN 503","503-09203","Placebo","Yes","Female","Black","Cape Town",NA,21,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-02557","Vaccine","Yes","Female","Black","Cape Town",NA,19,"Yes","Refused Further Participation","No","per SCHARP - study administrative pause","Yes","Yes","Yes"
"HVTN 503","503-12117","Placebo","Yes","Female","Black","Cape Town",NA,28,"No","End of Study","No","per scharp. administrative hold on product administration","No","Yes","Yes"
"HVTN 503","503-12774","Vaccine","Yes","Female","Black","Cape Town",NA,26,"Yes","Unable to Contact Participant","No","per SCHARP - study administrative pause","No","Yes","Yes"
"HVTN 503","503-05649","Vaccine","Yes","Female","Black","Cape Town",NA,30,"Yes","Investigator Decision","No","per scharp. administrative hold product administration.","Yes","Yes","Yes"
"HVTN 503","503-02344","Vaccine","Yes","Female","Black","Cape Town",NA,25,"No","End of Study","No","Per SCHARP - study administrative pause","No","Yes","Yes"
"HVTN 503","503-05108","Vaccine","Yes","Female","Black","Cape Town",NA,20,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-06574","Placebo","Yes","Female","Black","Cape Town",NA,19,"Yes","Unable to Contact Participant","No","per SCHARP - study administrative pause","No","Yes","No"
"HVTN 503","503-01947","Placebo","Yes","Female","Black","Cape Town",NA,20,"No","End of Study","No","Per SCHARP - study administrative pause","No","Yes","Yes"
"HVTN 503","503-01161","Placebo","Yes","Female","Black","Cape Town",NA,18,"No","End of Study","No","per SCHARP - study administrative pause","No","Yes","No"
"HVTN 503","503-13018","Placebo","Yes","Female","Black","Cape Town",NA,18,"No","End of Study","No","per SCHARP - study administrative pause","No","Yes","No"
"HVTN 503","503-07830","Placebo","Yes","Female","Black","Cape Town",NA,22,"No","End of Study","No","per scharp - study administrative pause","No","Yes","No"
"HVTN 503","503-07717","Placebo","Yes","Female","Black","Cape Town",NA,20,"No","End of Study","No","per SCHARP - study administrative pause","No","Yes","Yes"
"HVTN 503","503-09215","Placebo","Yes","Female","Black","Cape Town",NA,33,"No","End of Study","No","per SCHARP - administrative study pause","No","Yes","Yes"
"HVTN 503","503-01022","Placebo","Yes","Female","Black","Cape Town",NA,25,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-06239","Vaccine","Yes","Female","Black","Cape Town",NA,25,"Yes","Unable to Contact Participant","No","as per scharp instructions","No","Yes","Yes"
"HVTN 503","503-15101","Vaccine","Yes","Female","Black","Cape Town",NA,18,"No","End of Study","No","Efficacy pause as per SCHARP","No","Yes","No"
"HVTN 503","503-04659","Vaccine","Yes","Female","Black","Cape Town",NA,24,"No","End of Study","No","As per instructions from SCHARP","No","Yes","Yes"
"HVTN 503","503-11551","Vaccine","Yes","Female","Black","Cape Town",NA,28,"No","End of Study","No","per SCHARP - study administrative pause","No","Yes","Yes"
"HVTN 503","503-07711","Placebo","Yes","Female","Black","Cape Town",NA,22,"No","End of Study","No","efficacy pause","Yes","No","No"
"HVTN 503","503-01971","Placebo","Yes","Female","Black","Cape Town",NA,29,"No","End of Study","No","per scharp - study administrative pause","No","No","No"
"HVTN 503","503-14435","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",32,"No","End of Study","No","","Yes","Yes","No"
"HVTN 503","503-00815","Placebo","Yes","Male","Black","Cape Town","circumcised at baseline",32,"Yes","Unable to Contact Participant","No","","No","Yes","Yes"
"HVTN 503","503-00026","Placebo","Yes","Male","Black","Cape Town","circumcised at baseline",29,"No","End of Study","No","As per SCHARP Admin pause","No","Yes","Yes"
"HVTN 503","503-05610","Placebo","Yes","Male","Black","Cape Town","circumcised at baseline",31,"No","End of Study","No","","No","No","Yes"
"HVTN 503","503-08697","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",32,"Yes","Unable to Contact Participant","No","","Yes","Yes","Yes"
"HVTN 503","503-06301","Placebo","Yes","Male","Black","Cape Town","circumcised at baseline",23,"Yes","Unable to Contact Participant","No","per SCHARP - study administrative pause","No","Yes","No"
"HVTN 503","503-08247","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",32,"No","End of Study","No","per SCHARP -  administrative study pause","No","Yes","Yes"
"HVTN 503","503-09787","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",34,"No","End of Study","No","per scharp, adminstrative hold on product administration","Yes","Yes","Yes"
"HVTN 503","503-11807","Placebo","Yes","Male","Black","Cape Town","circumcised at baseline",30,"Yes","Unable to Contact Participant","No","As per SCHARP Admin Pause","No","Yes","No"
"HVTN 503","503-02110","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",31,"Yes","Unable to Contact Participant","No","HVTN 503 oversight committee decision","No","No","Yes"
"HVTN 503","503-01874","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",25,"No","End of Study","No","per scharp administrative hold on product administrations","No","Yes","No"
"HVTN 503","503-13542","Placebo","Yes","Male","Black","Cape Town","uncircumcised throughout the study",21,"No","End of Study","No","effacacy pause per SCHARP - study administrative pause.","No","Yes","No"
"HVTN 503","503-06331","Placebo","Yes","Male","Black","Cape Town","circumcised at baseline",27,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-13402","Placebo","Yes","Male","Black","Cape Town","circumcised at baseline",33,"Yes","Unable to Contact Participant","No","HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-11214","Vaccine","Yes","Male","Black","Cape Town","circumcised on study",24,"No","End of Study","No","hvtn 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-13676","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",29,"No","End of Study","No","as per HVTN 503 protocol oversight committee","No","Yes","Yes"
"HVTN 503","503-00885","Placebo","Yes","Male","Black","Cape Town","circumcised at baseline",28,"Yes","Unable to Contact Participant","No","HVTN oversight committee decision","Yes","No","No"
"HVTN 503","503-13217","Placebo","Yes","Male","Black","Cape Town","circumcised at baseline",29,"Yes","Participant Relocated","No","hvtn503 oversight committe decisions","No","Yes","No"
"HVTN 503","503-08912","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",26,"Yes","Unable to Contact Participant","No","HVTN oversight committee decision","No","Yes","No"
"HVTN 503","503-13707","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",26,"No","End of Study","No","HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-02955","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",21,"No","End of Study","No","HVTN 503 Oversight Committee decision","No","No","No"
"HVTN 503","503-14334","Placebo","Yes","Male","Black","Cape Town","uncircumcised at baseline and no follow-up circumcision assessment",22,"Yes","Refused Further Participation","No","Refused due to other reason","No","Yes","No"
"HVTN 503","503-06672","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",27,"Yes","Unable to Contact Participant","No","Unable to schedule","No","Yes","No"
"HVTN 503","503-07017","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",34,"Yes","Unable to Contact Participant","No","hvtn503 oversight committee decision","No","Yes","No"
"HVTN 503","503-03274","Placebo","Yes","Male","Black","Cape Town","circumcised at baseline",31,"Yes","Other","No","as per HVTN 503 committee","No","Yes","Yes"
"HVTN 503","503-08788","Placebo","Yes","Male","Black","Cape Town","circumcised at baseline",33,"No","End of Study","No","HVTN 503 protocol oversight committee decision","No","Yes","Yes"
"HVTN 503","503-04212","Placebo","Yes","Male","Black","Cape Town","uncircumcised throughout the study",24,"Yes","Death","Yes","hvtn503 oversight committee decision","No","No","No"
"HVTN 503","503-04483","Vaccine","Yes","Male","Black","Cape Town","circumcised on study",19,"No","End of Study","No","as per HVTN 503 oversight committee","No","No","No"
"HVTN 503","503-13889","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",25,"No","End of Study","No","HVTN 503 oversight committee decsion","No","Yes","No"
"HVTN 503","503-07038","Vaccine","Yes","Male","Black","Cape Town","uncircumcised throughout the study",23,"No","End of Study","No","hvtn 503 oversight committee decision","Yes","Yes","No"
"HVTN 503","503-07612","Placebo","Yes","Male","Black","Cape Town","circumcised on study",23,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-15387","Placebo","Yes","Male","Black","Cape Town","uncircumcised throughout the study",29,"Yes","Other","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-05696","Placebo","Yes","Male","Black","Cape Town","uncircumcised throughout the study",20,"Yes","Refused Further Participation","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-14382","Placebo","Yes","Male","Black","Cape Town","circumcised at baseline",24,"No","End of Study","No","as per HVTN 503 oversight commitee","No","No","No"
"HVTN 503","503-08500","Placebo","Yes","Male","Black","Cape Town","circumcised at baseline",22,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-05413","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",27,"Yes","Participant Relocated","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-11275","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",33,"Yes","Participant Relocated","No","503 oversight committee decision","No","Yes","No"
"HVTN 503","503-02043","Placebo","Yes","Male","Black","Cape Town","circumcised at baseline",23,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-14174","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",21,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-15344","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",22,"Yes","Unable to Contact Participant","No","HVTN 503 oversight committee decision.","Yes","Yes","Yes"
"HVTN 503","503-04654","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",25,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-10056","Placebo","Yes","Male","Black","Cape Town","uncircumcised throughout the study",20,"Yes","Participant Relocated","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-05130","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",29,"No","End of Study","No","as per HVTN 503 comittee decision","Yes","No","Yes"
"HVTN 503","503-12603","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",25,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-08179","Placebo","Yes","Male","Black","Cape Town","circumcised at baseline",32,"Yes","Unable to Contact Participant","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-10599","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",20,"No","End of Study","No","As per HVTN 503 oversight committee decision","Yes","No","No"
"HVTN 503","503-04779","Placebo","Yes","Male","Black","Cape Town","circumcised at baseline",29,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-09912","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",23,"No","End of Study","No","per scharp- study administrative pause","Yes","Yes","No"
"HVTN 503","503-03607","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",25,"Yes","Unable to Contact Participant","No","As per SCHARP Admin pause","No","Yes","No"
"HVTN 503","503-14046","Placebo","Yes","Male","Black","Cape Town","circumcised at baseline",23,"Yes","Refused Further Participation","No","per scharp. administrative hold on product administration","No","Yes","No"
"HVTN 503","503-14845","Placebo","Yes","Male","Black","Cape Town","circumcised at baseline",26,"No","End of Study","No","HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-00427","Placebo","Yes","Male","Black","Cape Town","circumcised at baseline",27,"Yes","Participant Relocated","No","As per SCHARP Oversight Committee decision","No","Yes","Yes"
"HVTN 503","503-11587","Vaccine","Yes","Male","Black","Cape Town","circumcised on study",23,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-13796","Placebo","Yes","Male","Black","Cape Town","circumcised at baseline",25,"Yes","Refused Further Participation","No","admin pause","No","Yes","No"
"HVTN 503","503-07360","Vaccine","Yes","Male","Black","Cape Town","circumcised on study",24,"Yes","Unable to Contact Participant","No","HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-14153","Placebo","Yes","Male","Black","Cape Town","uncircumcised throughout the study",21,"Yes","Death","Yes","Unable to schedule","No","Yes","No"
"HVTN 503","503-05723","Vaccine","Yes","Male","Black","Cape Town","circumcised on study",26,"No","End of Study","No","Unable to contact","No","Yes","Yes"
"HVTN 503","503-08601","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",21,"Yes","Participant Relocated","No","As Per SCHARP Admin Pause","No","No","No"
"HVTN 503","503-09345","Placebo","Yes","Male","Black","Cape Town","circumcised at baseline",28,"Yes","Unable to Contact Participant","No","HVTN 503 protocol oversight committee decision","No","Yes","Yes"
"HVTN 503","503-03694","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",27,"No","End of Study","No","per SCHARP - study administrative pause","Yes","Yes","Yes"
"HVTN 503","503-11171","Placebo","Yes","Male","Black","Cape Town","circumcised at baseline",28,"No","End of Study","No","per SCHARP - study administrative pause","No","Yes","Yes"
"HVTN 503","503-04936","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",32,"No","End of Study","No","as per SCHARP administrative pause","No","No","No"
"HVTN 503","503-03176","Placebo","Yes","Male","Black","Cape Town","circumcised at baseline",21,"No","End of Study","No","as per hvtn503 oversight committee","No","No","Yes"
"HVTN 503","503-01630","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",22,"Yes","Refused Further Participation","No","as per scharp","No","Yes","No"
"HVTN 503","503-04217","Vaccine","Yes","Male","Black","Cape Town","circumcised at baseline",21,"Yes","Unable to Contact Participant","No","efficacy pause. per SCHARP - study administrative pause.","No","Yes","No"
"HVTN 503","503-11270","Vaccine","Yes","Female","Black","Klerksdorp",NA,23,"No","End of Study","No","HVTN 503 oversight committee decision","Yes","Yes","No"
"HVTN 503","503-02773","Vaccine","Yes","Female","Black","Klerksdorp",NA,21,"No","End of Study","No","Per HVTN 503 Oversight Committee decision","No","Yes","No"
"HVTN 503","503-13581","Placebo","Yes","Female","Black","Klerksdorp",NA,22,"No","End of Study","No","per HVTN503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-00231","Placebo","Yes","Female","Black","Klerksdorp",NA,22,"No","End of Study","No","as per scharp instructions","No","Yes","No"
"HVTN 503","503-04244","Vaccine","Yes","Female","Black","Klerksdorp",NA,23,"No","End of Study","No","As per SCHARP instruction","No","Yes","No"
"HVTN 503","503-08444","Vaccine","Yes","Female","Black","Klerksdorp",NA,19,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-01752","Placebo","Yes","Female","Black","Klerksdorp",NA,20,"Yes","Unable to Contact Participant","No","Per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-15166","Vaccine","Yes","Female","Black","Klerksdorp",NA,19,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-07490","Vaccine","Yes","Female","Black","Klerksdorp",NA,23,"Yes","Investigator Decision","No","per HVTN 503 oversight committee discision","No","No","Yes"
"HVTN 503","503-02265","Placebo","Yes","Female","Black","Klerksdorp",NA,21,"Yes","Unable to Contact Participant","No","vaccinations were halted prior to participants scheduled vis","No","Yes","Yes"
"HVTN 503","503-15756","Placebo","Yes","Female","Black","Klerksdorp",NA,21,"No","End of Study","No","As per SCHARP instructions","No","Yes","No"
"HVTN 503","503-06097","Placebo","Yes","Female","Black","Klerksdorp",NA,26,"No","End of Study","No","per HVTN 503 oversight committee decision","Yes","No","No"
"HVTN 503","503-13341","Placebo","Yes","Female","Black","Klerksdorp",NA,20,"No","End of Study","No","hvtn 503 oversight committee decison.","No","No","No"
"HVTN 503","503-00639","Vaccine","Yes","Female","Black","Klerksdorp",NA,31,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-09449","Placebo","Yes","Female","Black","Klerksdorp",NA,21,"No","End of Study","No","Per hvtn 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-10142","Vaccine","Yes","Female","Black","Klerksdorp",NA,21,"Yes","Participant Relocated","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-03200","Vaccine","Yes","Female","Black","Klerksdorp",NA,19,"No","End of Study","No","per HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-11943","Vaccine","Yes","Female","Black","Klerksdorp",NA,24,"Yes","Unable to Contact Participant","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-03576","Placebo","Yes","Female","Black","Klerksdorp",NA,18,"No","End of Study","No","per HVTN 503 oversight committee decision","Yes","Yes","No"
"HVTN 503","503-06310","Vaccine","Yes","Female","Black","Klerksdorp",NA,28,"No","End of Study","No","per HVTN 503 oversight committee decision","Yes","Yes","Yes"
"HVTN 503","503-13219","Placebo","Yes","Female","Other","Klerksdorp",NA,25,"No","End of Study","No","Per HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-06569","Vaccine","Yes","Female","Black","Klerksdorp",NA,19,"No","End of Study","No","per HVTN503 oversight committee decision","No","Yes","No"
"HVTN 503","503-03654","Vaccine","Yes","Female","Black","Klerksdorp",NA,25,"No","End of Study","No","per HVTN 503 oversight committee decision","Yes","No","No"
"HVTN 503","503-06545","Vaccine","Yes","Female","Black","Klerksdorp",NA,21,"Yes","Refused Further Participation","No","participant withdrew participation","No","Yes","No"
"HVTN 503","503-03008","Vaccine","Yes","Female","Black","Klerksdorp",NA,18,"No","End of Study","No","Per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-01253","Vaccine","Yes","Female","Black","Klerksdorp",NA,20,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-11373","Placebo","Yes","Female","Black","Klerksdorp",NA,22,"Yes","Participant Relocated","No","Per hvtn 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-05470","Placebo","Yes","Female","Black","Klerksdorp",NA,30,"No","End of Study","No","HVTN 503 oversight committee decision","No","No","Yes"
"HVTN 503","503-02564","Placebo","Yes","Female","Black","Klerksdorp",NA,27,"No","End of Study","No","per HVTV 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-09989","Placebo","Yes","Female","Black","Klerksdorp",NA,22,"No","End of Study","No","HVTN 503 oversight committe decision","No","Yes","No"
"HVTN 503","503-11452","Placebo","Yes","Female","Black","Klerksdorp",NA,23,"No","End of Study","No","hvtn 503 oversight committee decision.","No","Yes","No"
"HVTN 503","503-06566","Placebo","Yes","Female","Black","Klerksdorp",NA,25,"Yes","Other","No","Per HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-00036","Placebo","Yes","Female","Other","Klerksdorp",NA,22,"No","End of Study","No","per HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-00379","Placebo","Yes","Female","Black","Klerksdorp",NA,18,"Yes","Other","No","requested by scharp","No","Yes","Yes"
"HVTN 503","503-13849","Vaccine","Yes","Female","Black","Klerksdorp",NA,24,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-04047","Vaccine","Yes","Female","Black","Klerksdorp",NA,19,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-01633","Vaccine","Yes","Female","Black","Klerksdorp",NA,19,"Yes","Participant Relocated","No","as per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-07701","Placebo","Yes","Female","Black","Klerksdorp",NA,22,"Yes","Participant Relocated","No","as per HVTN oversight committee dicision","No","No","No"
"HVTN 503","503-00935","Vaccine","Yes","Female","Black","Klerksdorp",NA,19,"No","End of Study","No","Post HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-05465","Placebo","Yes","Female","Black","Klerksdorp",NA,21,"No","End of Study","No","Requested by SCHARP","No","Yes","Yes"
"HVTN 503","503-07672","Vaccine","Yes","Female","Black","Klerksdorp",NA,27,"Yes","Other","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-06877","Vaccine","Yes","Female","Black","Klerksdorp",NA,27,"No","End of Study","No","per HVTN 503 oversight committee decision","Yes","Yes","No"
"HVTN 503","503-01635","Vaccine","Yes","Female","Black","Klerksdorp",NA,28,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-09448","Vaccine","Yes","Female","Black","Klerksdorp",NA,23,"No","End of Study","No","per HVTN for oversight committee decision","No","Yes","No"
"HVTN 503","503-13985","Vaccine","Yes","Female","Black","Klerksdorp",NA,21,"No","End of Study","No","As per HVTN 503 oversight committee decision.","No","No","No"
"HVTN 503","503-15090","Placebo","Yes","Female","Black","Klerksdorp",NA,20,"No","End of Study","No","Per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-15973","Placebo","Yes","Female","Black","Klerksdorp",NA,22,"No","End of Study","No","per HVTN 503 Oversight Committee Decision","No","Yes","No"
"HVTN 503","503-00525","Vaccine","Yes","Female","Black","Klerksdorp",NA,29,"Yes","Refused Further Participation","No","as per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-10455","Placebo","Yes","Female","Black","Klerksdorp",NA,27,"No","End of Study","No","per hvtn 503 oversight committee decision","No","No","Yes"
"HVTN 503","503-00709","Placebo","Yes","Female","Black","Klerksdorp",NA,19,"No","End of Study","No","Per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-11731","Placebo","Yes","Female","Black","Klerksdorp",NA,25,"Yes","Unable to Contact Participant","No","request by SCHARP.","No","Yes","Yes"
"HVTN 503","503-05281","Vaccine","Yes","Female","Black","Klerksdorp",NA,21,"No","End of Study","No","per SCHARP hold","No","Yes","No"
"HVTN 503","503-07729","Placebo","Yes","Female","Black","Klerksdorp",NA,20,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-11626","Vaccine","Yes","Female","Black","Klerksdorp",NA,25,"No","End of Study","No","per HVTN503 oversight committee decision","No","Yes","No"
"HVTN 503","503-07941","Vaccine","Yes","Female","Black","Klerksdorp",NA,22,"No","End of Study","No","as per scharp's request","No","Yes","Yes"
"HVTN 503","503-05964","Placebo","Yes","Female","Black","Klerksdorp",NA,20,"No","End of Study","No","per SCHARP administrative hold","No","Yes","No"
"HVTN 503","503-15520","Vaccine","Yes","Female","Black","Klerksdorp",NA,19,"Yes","Other","No","as per scharp's request","No","Yes","No"
"HVTN 503","503-06176","Vaccine","Yes","Female","Black","Klerksdorp",NA,18,"Yes","Refused Further Participation","No","As per SCHARP admin hold.","No","No","No"
"HVTN 503","503-08819","Vaccine","Yes","Female","Black","Klerksdorp",NA,25,"Yes","Participant Relocated","No","Per scharp administrative hold.","Yes","No","Yes"
"HVTN 503","503-01636","Placebo","Yes","Female","Black","Klerksdorp",NA,20,"Yes","Refused Further Participation","No","per HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-09469","Placebo","Yes","Female","Black","Klerksdorp",NA,25,"No","End of Study","No","as per scharp administrative hold.","No","No","No"
"HVTN 503","503-12250","Vaccine","Yes","Female","Black","Klerksdorp",NA,19,"Yes","Other","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-13095","Placebo","Yes","Female","Black","Klerksdorp",NA,18,"No","End of Study","No","requested by Scharp","No","Yes","Yes"
"HVTN 503","503-12263","Placebo","Yes","Female","Black","Klerksdorp",NA,22,"Yes","Unable to Contact Participant","No","As per SCHARP Safety Hold.","No","Yes","No"
"HVTN 503","503-07857","Vaccine","Yes","Female","Black","Klerksdorp",NA,24,"No","End of Study","No","as per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-03559","Placebo","Yes","Female","Black","Klerksdorp",NA,20,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-14266","Placebo","Yes","Female","Black","Klerksdorp",NA,24,"Yes","Unable to Contact Participant","No","as per HVTN oversight committee decision.","No","Yes","No"
"HVTN 503","503-02272","Vaccine","Yes","Female","Black","Klerksdorp",NA,22,"No","End of Study","No","as per SCHARP's administration hold request","No","No","No"
"HVTN 503","503-01671","Placebo","Yes","Female","Black","Klerksdorp",NA,24,"Yes","Participant Relocated","No","HVTN 503 oversight committee decision.","No","Yes","No"
"HVTN 503","503-03535","Vaccine","Yes","Female","Black","Klerksdorp",NA,22,"Yes","Other","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-13249","Placebo","Yes","Female","Black","Klerksdorp",NA,23,"No","End of Study","No","per HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-03199","Vaccine","Yes","Female","Black","Klerksdorp",NA,19,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-02483","Placebo","Yes","Female","Black","Klerksdorp",NA,19,"No","End of Study","No","per HVTN 503 oversight committee decision","Yes","Yes","No"
"HVTN 503","503-04546","Placebo","Yes","Female","Black","Klerksdorp",NA,24,"No","End of Study","No","as per scharp instructions","No","Yes","No"
"HVTN 503","503-06394","Placebo","Yes","Female","Black","Klerksdorp",NA,20,"Yes","Other","No","Request from SCHARP","No","No","No"
"HVTN 503","503-00537","Vaccine","Yes","Female","Black","Klerksdorp",NA,23,"No","End of Study","No","requested by SCHARP","No","Yes","Yes"
"HVTN 503","503-15649","Placebo","Yes","Female","Black","Klerksdorp",NA,31,"Yes","Participant Relocated","No","As per SCHARP's administration hold","No","Yes","Yes"
"HVTN 503","503-01382","Vaccine","Yes","Male","Black","Klerksdorp","circumcised on study",25,"No","End of Study","No","SCHARP decision to hold.","No","Yes","No"
"HVTN 503","503-14719","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",25,"Yes","Other","No","per HVTN oversight committee decision","No","Yes","Yes"
"HVTN 503","503-08720","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",27,"No","End of Study","No","as per HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-07227","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",20,"No","End of Study","No","as per scharp administration hold","No","Yes","No"
"HVTN 503","503-09400","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised at baseline and no follow-up circumcision assessment",21,"Yes","Other","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-02921","Placebo","Yes","Male","Black","Klerksdorp","circumcised on study",30,"No","End of Study","No","requested by SCHARP","No","Yes","No"
"HVTN 503","503-08096","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",24,"No","End of Study","No","as per scharp instructions","No","Yes","No"
"HVTN 503","503-11805","Vaccine","Yes","Male","Black","Klerksdorp","circumcised at baseline",21,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-10821","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",31,"No","End of Study","No","SCHARP administrative hold.","No","No","Yes"
"HVTN 503","503-11989","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",35,"No","End of Study","No","Per hvtn 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-05894","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",23,"Yes","Unable to Contact Participant","No","as per SCHARP instruction","No","Yes","No"
"HVTN 503","503-15883","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",21,"No","End of Study","No","HVTN 503 oversight decision","No","Yes","No"
"HVTN 503","503-13088","Vaccine","Yes","Male","Black","Klerksdorp","circumcised on study",23,"Yes","Refused Further Participation","No","requested per scharp","No","Yes","No"
"HVTN 503","503-11933","Vaccine","Yes","Male","Black","Klerksdorp","circumcised on study",27,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-05243","Placebo","Yes","Male","Black","Klerksdorp","circumcised on study",20,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-15405","Placebo","Yes","Male","Other","Klerksdorp","circumcised on study",21,"Yes","Unable to Contact Participant","No","HVTN 503 oversight committee decision","Yes","Yes","No"
"HVTN 503","503-07989","Vaccine","Yes","Male","Black","Klerksdorp","circumcised on study",19,"Yes","Participant Relocated","No","as per SCHARP instructions","No","No","No"
"HVTN 503","503-07239","Placebo","Yes","Male","Black","Klerksdorp","circumcised on study",20,"No","End of Study","No","Required by SCHARP","No","Yes","No"
"HVTN 503","503-00793","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",24,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-09634","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",23,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-11970","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",18,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-10870","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",19,"No","End of Study","No","per HVTN 503 oversight committee discision","No","No","No"
"HVTN 503","503-06354","Vaccine","Yes","Male","Black","Klerksdorp","circumcised on study",24,"No","End of Study","No","As per HVTN 503 oversight committee decision.","No","Yes","No"
"HVTN 503","503-15545","Vaccine","Yes","Male","Black","Klerksdorp","circumcised on study",20,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-09297","Placebo","Yes","Male","Black","Klerksdorp","circumcised at baseline",24,"Yes","Participant Relocated","No","Per hvtn 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-01211","Vaccine","Yes","Male","Black","Klerksdorp","circumcised at baseline",28,"No","End of Study","No","Clinical Event other than reactogenicity or HIV infection","No","Yes","Yes"
"HVTN 503","503-13703","Placebo","Yes","Male","Black","Klerksdorp","circumcised on study",20,"No","End of Study","No","per HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-13175","Placebo","Yes","Male","Black","Klerksdorp","circumcised at baseline",21,"No","End of Study","No","as per scharp instructions","No","Yes","No"
"HVTN 503","503-08549","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised at baseline and no follow-up circumcision assessment",34,"Yes","Participant Relocated","No","Unable to schedule","No","Yes","No"
"HVTN 503","503-07740","Vaccine","Yes","Male","Black","Klerksdorp","circumcised on study",23,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-09463","Placebo","Yes","Male","Black","Klerksdorp","circumcised at baseline",27,"Yes","Participant Relocated","No","Per HVTN 503 oversight committee","No","Yes","No"
"HVTN 503","503-01440","Placebo","Yes","Male","Black","Klerksdorp","circumcised on study",22,"Yes","Unable to Contact Participant","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-13082","Vaccine","Yes","Male","Black","Klerksdorp","circumcised at baseline",20,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-10900","Placebo","Yes","Male","Black","Klerksdorp","circumcised on study",23,"No","End of Study","No","As per HVTN oversight commitee decision.","No","No","No"
"HVTN 503","503-07889","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",21,"Yes","Refused Further Participation","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-02952","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",22,"Yes","Other","No","per HVTN503 oversight committee decision","No","Yes","No"
"HVTN 503","503-04950","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",22,"Yes","Participant Relocated","No","per HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-08327","Vaccine","Yes","Male","Black","Klerksdorp","circumcised at baseline",24,"Yes","Refused Further Participation","No","Refused due to other person concern","No","No","No"
"HVTN 503","503-05828","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",18,"Yes","Refused Further Participation","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-03202","Vaccine","Yes","Male","Black","Klerksdorp","circumcised on study",23,"No","End of Study","No","per HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-02159","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",23,"No","End of Study","No","per HVTN oversight committee decision","No","Yes","No"
"HVTN 503","503-09783","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",27,"No","End of Study","No","Unable to contact","No","No","No"
"HVTN 503","503-13479","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",22,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-05496","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",24,"No","End of Study","No","as per HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-07682","Placebo","Yes","Male","Black","Klerksdorp","circumcised on study",22,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-09619","Placebo","Yes","Male","Black","Klerksdorp","circumcised on study",21,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-03311","Placebo","Yes","Male","Black","Klerksdorp","circumcised on study",20,"No","End of Study","No","Per hvtn 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-01196","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",21,"No","End of Study","No","per HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-10617","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",18,"Yes","Other","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-06485","Placebo","Yes","Male","Black","Klerksdorp","circumcised at baseline",26,"Yes","Unable to Contact Participant","No","vaccinations discontinued","Yes","No","No"
"HVTN 503","503-12472","Vaccine","Yes","Male","Black","Klerksdorp","circumcised on study",25,"No","End of Study","No","per HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-00336","Vaccine","Yes","Male","Black","Klerksdorp","circumcised on study",20,"No","End of Study","No","per hvtn 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-04733","Vaccine","Yes","Male","Black","Klerksdorp","circumcised at baseline",26,"No","End of Study","No","per HVTN 503 oversight committe decision","No","Yes","No"
"HVTN 503","503-05618","Placebo","Yes","Male","Black","Klerksdorp","circumcised on study",21,"No","End of Study","No","Per hvtn 503 Oversight committee decision","No","Yes","No"
"HVTN 503","503-13647","Vaccine","Yes","Male","Black","Klerksdorp","circumcised on study",21,"No","End of Study","No","Per HVTN oversight committee decision.","No","Yes","Yes"
"HVTN 503","503-09353","Vaccine","Yes","Male","Black","Klerksdorp","circumcised on study",20,"No","End of Study","No","Per hvtn 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-01677","Vaccine","Yes","Male","Black","Klerksdorp","circumcised on study",22,"No","End of Study","No","per HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-11113","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",18,"Yes","Investigator Decision","No","per hvtn 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-02868","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",21,"Yes","Other","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-13884","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",22,"No","End of Study","No","per HVTN503 oversight committee decision","No","No","No"
"HVTN 503","503-09819","Vaccine","Yes","Male","Black","Klerksdorp","circumcised on study",20,"No","End of Study","No","As per HVTN 503 oversight commitee decision","No","Yes","No"
"HVTN 503","503-01659","Placebo","Yes","Male","Black","Klerksdorp","circumcised at baseline",20,"Yes","Unable to Contact Participant","No","per HVTN 503 oversight committee decission","No","No","No"
"HVTN 503","503-01582","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",22,"Yes","Other","No","as per hvtn 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-10395","Placebo","Yes","Male","Black","Klerksdorp","circumcised on study",21,"No","End of Study","No","Per HVTN oversight committee decision","No","Yes","No"
"HVTN 503","503-10023","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",21,"No","End of Study","No","Per HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-00483","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",21,"No","End of Study","No","per hvtn503 oversight committee decision","No","Yes","No"
"HVTN 503","503-06183","Placebo","Yes","Male","Black","Klerksdorp","circumcised at baseline",29,"No","End of Study","No","as per HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-08064","Placebo","Yes","Male","Black","Klerksdorp","circumcised at baseline",19,"No","End of Study","No","Per hvtn 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-07470","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",21,"Yes","Unable to Contact Participant","No","Per hvtn 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-02058","Vaccine","Yes","Male","Black","Klerksdorp","circumcised on study",30,"No","End of Study","No","as per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-00189","Placebo","Yes","Male","Black","Klerksdorp","circumcised at baseline",20,"Yes","Unable to Contact Participant","No","as per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-10206","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",22,"No","End of Study","No","As per HVTN 503 oversight commitee decision","Yes","Yes","No"
"HVTN 503","503-02602","Placebo","Yes","Male","Black","Klerksdorp","circumcised on study",22,"Yes","Other","No","as per HVTN 503 oversight committee decision","Yes","Yes","Yes"
"HVTN 503","503-03702","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",20,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-05904","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",23,"Yes","Unable to Contact Participant","No","request from SCHARP","Yes","Yes","Yes"
"HVTN 503","503-06820","Vaccine","Yes","Male","Black","Klerksdorp","circumcised on study",21,"No","End of Study","No","Per HVTN 503 Oversight Committee decision","No","Yes","No"
"HVTN 503","503-11614","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",19,"Yes","Unable to Contact Participant","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-11810","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",28,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-03024","Vaccine","Yes","Male","Black","Klerksdorp","circumcised on study",19,"No","End of Study","No","as per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-12305","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",25,"No","End of Study","No","per hvtn 503 oversight committee decision","Yes","Yes","No"
"HVTN 503","503-06040","Placebo","Yes","Male","Black","Klerksdorp","circumcised on study",19,"No","End of Study","No","Requested by Scharp","No","Yes","No"
"HVTN 503","503-04179","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",23,"Yes","Unable to Contact Participant","No","HVTN 503  oversight committee decision.","No","Yes","No"
"HVTN 503","503-13306","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",22,"No","End of Study","No","requested by SCHARP","Yes","Yes","No"
"HVTN 503","503-04278","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",18,"No","End of Study","No","Per hvtn 503 oversight decision committee","Yes","Yes","No"
"HVTN 503","503-03494","Placebo","Yes","Male","Black","Klerksdorp","circumcised on study",20,"No","End of Study","No","per HVTN 503 oversite committee decision","No","Yes","No"
"HVTN 503","503-04375","Placebo","Yes","Male","Black","Klerksdorp","circumcised on study",18,"Yes","Unable to Contact Participant","No","Unable to contact","No","Yes","No"
"HVTN 503","503-10034","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",21,"No","End of Study","No","HVTN 503 oversight committee decision.","No","Yes","No"
"HVTN 503","503-08170","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",20,"No","End of Study","No","per HVTN503 oversight committee decision","No","No","Yes"
"HVTN 503","503-14691","Placebo","Yes","Male","Other","Klerksdorp","uncircumcised throughout the study",31,"No","End of Study","No","per HVTN 503 oversight committe decision","No","Yes","No"
"HVTN 503","503-12810","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",22,"Yes","Unable to Contact Participant","No","Per hvtn 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-01796","Placebo","Yes","Male","Black","Klerksdorp","circumcised at baseline",34,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-15792","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",23,"No","End of Study","No","per hvtn 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-13296","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",20,"Yes","Other","No","per HVTN 503 oversight commettee decision","No","Yes","No"
"HVTN 503","503-05778","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",23,"Yes","Other","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-00006","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",22,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-01822","Placebo","Yes","Male","Black","Klerksdorp","circumcised at baseline",23,"Yes","Other","No","per scharp admin hold","No","No","No"
"HVTN 503","503-11298","Placebo","Yes","Male","Black","Klerksdorp","circumcised at baseline",20,"No","End of Study","No","requested by SCHARP","No","Yes","No"
"HVTN 503","503-08968","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",20,"Yes","Refused Further Participation","No","per HVTN503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-06049","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",19,"No","End of Study","No","per HVTN 503 oversight committee decision","Yes","Yes","No"
"HVTN 503","503-13073","Placebo","Yes","Male","Black","Klerksdorp","circumcised on study",27,"No","End of Study","No","per HVTN 503 oversight committee decision","No","No","Yes"
"HVTN 503","503-06348","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",23,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-11228","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised at baseline and no follow-up circumcision assessment",22,"Yes","Unable to Contact Participant","No","Unable to contact","No","Yes","No"
"HVTN 503","503-04469","Placebo","Yes","Male","Black","Klerksdorp","circumcised on study",21,"Yes","Unable to Contact Participant","No","per HVTN 503 oversight decision committee","No","Yes","No"
"HVTN 503","503-00664","Placebo","Yes","Male","Black","Klerksdorp","circumcised on study",19,"No","End of Study","No","As per SCHARP's administrative hold","No","Yes","No"
"HVTN 503","503-13670","Vaccine","Yes","Male","Black","Klerksdorp","circumcised at baseline",25,"Yes","Participant Relocated","No","per HVTN 503 oversight committee decision","No","No","Yes"
"HVTN 503","503-14750","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",25,"Yes","Participant Relocated","No","Unable to schedule","No","Yes","No"
"HVTN 503","503-07876","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",24,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-07149","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",20,"No","End of Study","No","as per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-12230","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",24,"Yes","Unable to Contact Participant","No","request from SCHARP","No","Yes","No"
"HVTN 503","503-00096","Vaccine","Yes","Male","Black","Klerksdorp","circumcised at baseline",18,"Yes","Participant Relocated","No","hvtn 503 oversight committee decision.","No","Yes","No"
"HVTN 503","503-06951","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",20,"Yes","Unable to Contact Participant","No","Per HVTN 503 Oversight Committee decision","No","Yes","No"
"HVTN 503","503-09673","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",21,"No","End of Study","No","Request by SCHARP","No","Yes","No"
"HVTN 503","503-14411","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",24,"No","End of Study","No","For hvtn 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-09632","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",21,"No","End of Study","No","as per scharp's request","No","Yes","No"
"HVTN 503","503-03153","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",19,"No","End of Study","No","requested by SCHARP","No","Yes","No"
"HVTN 503","503-13620","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",18,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-05201","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised at baseline and no follow-up circumcision assessment",18,"Yes","Participant Relocated","No","as per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-01286","Placebo","Yes","Male","Black","Klerksdorp","circumcised on study",20,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-02627","Vaccine","Yes","Male","Black","Klerksdorp","circumcised at baseline",22,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-15139","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",21,"Yes","Unable to Contact Participant","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-14715","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",20,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-12767","Vaccine","Yes","Male","Black","Klerksdorp","circumcised on study",22,"No","End of Study","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-08336","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",25,"No","End of Study","No","as per SCHARP administrative hold.","No","Yes","No"
"HVTN 503","503-02290","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",18,"Yes","Other","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-14251","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",22,"Yes","Other","No","requested by scharp","No","Yes","No"
"HVTN 503","503-12685","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised at baseline and no follow-up circumcision assessment",19,"Yes","Participant Relocated","No","Requested by SCHARP","No","Yes","No"
"HVTN 503","503-04140","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",30,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-14602","Vaccine","Yes","Male","Black","Klerksdorp","circumcised on study",25,"Yes","Other","No","request by SCHARP","No","Yes","No"
"HVTN 503","503-14776","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",19,"Yes","Participant Relocated","No","Per HVTN Oversight Committee decision.","No","Yes","No"
"HVTN 503","503-13502","Placebo","Yes","Male","Black","Klerksdorp","circumcised at baseline",34,"No","End of Study","No","As per SCHARP request.","No","Yes","No"
"HVTN 503","503-08079","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",28,"No","End of Study","No","requested by SCHARP","No","Yes","Yes"
"HVTN 503","503-15064","Placebo","Yes","Male","Black","Klerksdorp","circumcised on study",23,"Yes","Unable to Contact Participant","No","request from SHARP.","No","Yes","No"
"HVTN 503","503-09220","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",22,"Yes","Participant Relocated","No","per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-11038","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",19,"No","End of Study","No","per scharp pause.","No","No","No"
"HVTN 503","503-11161","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",19,"Yes","Unable to Contact Participant","No","As per HVTN oversight committee decision","No","Yes","No"
"HVTN 503","503-04763","Placebo","Yes","Male","Black","Klerksdorp","circumcised on study",26,"No","End of Study","No","Per HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-04095","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised at baseline and no follow-up circumcision assessment",22,"Yes","Participant Relocated","No","per HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-06557","Vaccine","Yes","Male","Black","Klerksdorp","circumcised on study",20,"No","End of Study","No","Per HVTN oversight committee decision.","No","Yes","No"
"HVTN 503","503-15976","Placebo","Yes","Male","Black","Klerksdorp","circumcised at baseline",19,"No","End of Study","No","request by SCHARP","No","Yes","No"
"HVTN 503","503-09283","Vaccine","Yes","Male","Black","Klerksdorp","circumcised on study",19,"No","End of Study","No","as per SCHARP's administration safety hold","No","Yes","No"
"HVTN 503","503-01331","Vaccine","Yes","Male","Black","Klerksdorp","circumcised on study",20,"No","End of Study","No","HVTN 503 oversight committee decision.","No","Yes","No"
"HVTN 503","503-01632","Placebo","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",18,"Yes","Other","No","instructions as per scharp.","No","Yes","No"
"HVTN 503","503-04786","Placebo","Yes","Male","Black","Klerksdorp","circumcised at baseline",19,"Yes","Other","No","as per SCHARP instruction","No","Yes","No"
"HVTN 503","503-06535","Vaccine","Yes","Male","Black","Klerksdorp","uncircumcised throughout the study",18,"Yes","Participant Relocated","No","per HVTN 503 oversight committee decision","No","No","No"
"HVTN 503","503-14204","Vaccine","Yes","Female","Black","eThekwini",NA,18,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-13580","Vaccine","Yes","Female","Black","eThekwini",NA,21,"No","End of Study","No","HVTN 503 oversight committee decision","Yes","No","No"
"HVTN 503","503-05589","Vaccine","Yes","Female","Black","eThekwini",NA,20,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-04312","Placebo","Yes","Female","Black","eThekwini",NA,25,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-05303","Placebo","Yes","Female","Black","eThekwini",NA,19,"No","End of Study","No","HVTN 503 study oversight committee decision","No","No","No"
"HVTN 503","503-00844","Vaccine","Yes","Female","Black","eThekwini",NA,18,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-00544","Placebo","Yes","Female","Black","eThekwini",NA,27,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-00589","Vaccine","Yes","Female","Black","eThekwini",NA,30,"Yes","Refused Further Participation","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-04994","Placebo","Yes","Female","Black","eThekwini",NA,22,"No","End of Study","No","HVTN 503 study discontinued due to efficacy reasons","Yes","Yes","No"
"HVTN 503","503-03257","Placebo","Yes","Female","Black","eThekwini",NA,20,"No","End of Study","No","HVTN 503 oversight committee decision","Yes","Yes","No"
"HVTN 503","503-04250","Vaccine","Yes","Female","Black","eThekwini",NA,23,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-09904","Placebo","Yes","Female","Black","eThekwini",NA,26,"No","End of Study","No","Pregnancy","No","Yes","Yes"
"HVTN 503","503-06994","Placebo","Yes","Female","Black","eThekwini",NA,22,"No","End of Study","No","failure in efficacy of htvn 503 vaccine","Yes","Yes","No"
"HVTN 503","503-09003","Placebo","Yes","Female","Black","eThekwini",NA,23,"No","End of Study","No","oversight committee decison from hvtn 503","Yes","Yes","No"
"HVTN 503","503-04394","Vaccine","Yes","Female","Black","eThekwini",NA,26,"No","End of Study","No","HVTN 503 STUDY DISCONTINUED DUE TO EFFICACY REASONS","Yes","Yes","Yes"
"HVTN 503","503-03543","Vaccine","Yes","Female","Black","eThekwini",NA,26,"No","End of Study","No","HVTN oversight comittee decision","Yes","Yes","Yes"
"HVTN 503","503-04071","Placebo","Yes","Female","Black","eThekwini",NA,26,"No","End of Study","No","HVTN 503 study discontinued due to efficacy reasons","No","No","No"
"HVTN 503","503-02797","Placebo","Yes","Female","Black","eThekwini",NA,26,"No","End of Study","No","HVTN 503 study discontinued due to efficacy reasons.","No","Yes","No"
"HVTN 503","503-02150","Placebo","Yes","Female","Black","eThekwini",NA,22,"No","End of Study","No","HVTN 503 study discontinued due to efficacy","No","No","No"
"HVTN 503","503-08915","Vaccine","Yes","Female","Black","eThekwini",NA,29,"No","End of Study","No","HVTN 503 discontinued due to efficacy","No","No","Yes"
"HVTN 503","503-01725","Vaccine","Yes","Female","Black","eThekwini",NA,31,"No","End of Study","No","HVTN 503 study discontinued due to efficacy reasons","No","Yes","Yes"
"HVTN 503","503-02687","Placebo","Yes","Female","Black","eThekwini",NA,23,"No","End of Study","No","HVTN 503 discontinued due to oversight committee decision","No","Yes","Yes"
"HVTN 503","503-01530","Vaccine","Yes","Female","Black","eThekwini",NA,31,"No","End of Study","No","HVTN 503 study discontinued due to efficacy","No","No",NA
"HVTN 503","503-08418","Vaccine","Yes","Female","Black","eThekwini",NA,20,"No","End of Study","No","HVTN 503 discontinued due to efficacy reasons.","No","Yes","No"
"HVTN 503","503-04506","Placebo","Yes","Male","Black","eThekwini","circumcised on study",26,"No","End of Study","No","HVTN503 discontinued due to efficacy","No","Yes","No"
"HVTN 503","503-03963","Vaccine","Yes","Male","Black","eThekwini","uncircumcised throughout the study",19,"No","End of Study","No","HVTN 503 study discontinued due to efficacy reasons","Yes","No","No"
"HVTN 503","503-01852","Placebo","Yes","Male","Black","eThekwini","uncircumcised throughout the study",21,"No","End of Study","No","hvtn 503 oversight committee decision.","No","Yes","No"
"HVTN 503","503-01244","Placebo","Yes","Male","Black","eThekwini","circumcised on study",22,"No","End of Study","No","HVTN 503 oversight committee decision","Yes","Yes","No"
"HVTN 503","503-14831","Vaccine","Yes","Male","Black","eThekwini","circumcised on study",19,"No","End of Study","No","hvtn 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-05757","Vaccine","Yes","Male","Black","eThekwini","circumcised on study",20,"Yes","Other","No","HVTN 503 study discontinued due to efficacy reasons.","No","No","No"
"HVTN 503","503-15865","Placebo","Yes","Male","Black","eThekwini","circumcised on study",24,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-13766","Vaccine","Yes","Male","Black","eThekwini","circumcised on study",29,"No","End of Study","No","HVTN 503 ovesight committee decision","No","Yes","Yes"
"HVTN 503","503-15014","Vaccine","Yes","Male","Black","eThekwini","uncircumcised throughout the study",31,"No","End of Study","No","HVTN503 oversight committee decision","Yes","Yes","Yes"
"HVTN 503","503-14249","Placebo","Yes","Male","Black","eThekwini","circumcised at baseline",25,"Yes","Refused Further Participation","No","HVTN503 oversight committee decision","No","No","Yes"
"HVTN 503","503-07464","Vaccine","Yes","Male","Black","eThekwini","uncircumcised throughout the study",21,"No","End of Study","No","Clinical Event other than reactogenicity or HIV infection","Yes","Yes","No"
"HVTN 503","503-14526","Vaccine","Yes","Male","Black","eThekwini","circumcised on study",29,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-12987","Vaccine","Yes","Male","Black","eThekwini","circumcised on study",33,"No","End of Study","No","HVTN503 discontinued due to efficacy","No","Yes","Yes"
"HVTN 503","503-14476","Placebo","Yes","Male","Black","eThekwini","circumcised on study",22,"No","End of Study","No","HVTN 503 oversight committee decision","No","No","Yes"
"HVTN 503","503-11712","Vaccine","Yes","Male","Black","eThekwini","circumcised on study",24,"No","End of Study","No","halt in HVTN 503 vaccinations due to failure in efficacy","Yes","No","Yes"
"HVTN 503","503-04005","Placebo","Yes","Male","Black","eThekwini","circumcised on study",26,"No","End of Study","No","failure in efficacy of HVTN 503 study product","No","No","No"
"HVTN 503","503-02452","Vaccine","Yes","Male","Black","eThekwini","circumcised on study",32,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-07226","Placebo","Yes","Male","Black","eThekwini","circumcised on study",19,"No","End of Study","No","discontinuation of hvtn503 study product administration due","No","Yes","No"
"HVTN 503","503-04780","Placebo","Yes","Male","Black","eThekwini","uncircumcised throughout the study",18,"No","End of Study","No","HVTN 503 oversight committee decision","No","Yes","No"
"HVTN 503","503-11194","Vaccine","Yes","Male","Black","eThekwini","circumcised on study",24,"No","End of Study","No","HVTN 503 study discontinued due to efficacy reasons","No","No","No"
"HVTN 503","503-00149","Placebo","Yes","Male","Black","eThekwini","circumcised on study",27,"Yes","Other","No","HVTN 503 oversight committee decision","No","Yes","Yes"
"HVTN 503","503-00146","Vaccine","Yes","Male","Black","eThekwini","circumcised on study",22,"Yes","Other","No","HVTN 503 discontinued due to admin hold","Yes","Yes","No"
"HVTN 503","503-08939","Placebo","Yes","Male","Black","eThekwini","circumcised on study",29,"No","End of Study","No","HVTN 503 study product discontinued due to efficacy failure","No","No","No"
"HVTN 503","503-14109","Placebo","Yes","Male","Black","eThekwini","circumcised on study",28,"No","End of Study","No","HVTN 503 study discontinued due to efficacy reasons.","No","Yes","No"
"HVTN 503","503-05884","Placebo","Yes","Male","Black","eThekwini","uncircumcised throughout the study",18,"Yes","Unable to Contact Participant","No","hvtn 503 study discontinued due to efficacy","No","No",NA
"HVTN 503","503-06834","Vaccine","Yes","Male","Black","eThekwini","circumcised on study",27,"No","End of Study","No","hvtn503 study discontinued due to efficacy","No","No","Yes"
"HVTN 503","503-10452","Placebo","Yes","Male","Black","eThekwini","circumcised on study",29,"No","End of Study","No","HVTN 503 study discontinued due to admin hold","No","Yes","No"
"HVTN 503","503-12839","Placebo","Yes","Male","Black","eThekwini","circumcised on study",30,"No","End of Study","No","HVTN 503 study discontinued due to efficacy","No","Yes","Yes"
"HVTN 503","503-10388","Vaccine","Yes","Male","Black","eThekwini","circumcised on study",29,"No","End of Study","No","HVTN503 study discontinued due to efficacy","No","Yes","No"
"HVTN 503","503-01322","Placebo","Yes","Female","Black","Medunsa",NA,22,"No","End of Study","No","study vaccinations stopped","No","Yes","No"
"HVTN 503","503-09111","Vaccine","Yes","Female","Black","Medunsa",NA,34,"Yes","Unable to Contact Participant","No","vaccinations on hold","No","No","No"
"HVTN 503","503-11277","Placebo","Yes","Female","Black","Medunsa",NA,20,"No","End of Study","No","vaccination on hold","No","Yes","No"
"HVTN 503","503-14992","Vaccine","Yes","Female","Black","Medunsa",NA,22,"No","End of Study","No","study vaccinations stopped","No","Yes","No"
"HVTN 503","503-13583","Placebo","Yes","Female","Black","Medunsa",NA,33,"No","End of Study","No","vaccination stopped","No","No","Yes"
"HVTN 503","503-11070","Placebo","Yes","Female","Black","Medunsa",NA,23,"No","End of Study","No","vaccinations discontinued, decision by dsmb","Yes","Yes","No"
"HVTN 503","503-05973","Placebo","Yes","Female","Black","Medunsa",NA,22,"No","End of Study","No","vaccinations on hold","No","Yes","No"
"HVTN 503","503-08264","Vaccine","Yes","Female","Black","Medunsa",NA,34,"No","End of Study","No","study vaccinations stopped","No","Yes","No"
"HVTN 503","503-04414","Vaccine","Yes","Female","Black","Medunsa",NA,33,"No","End of Study","No","Unable to schedule","No","Yes","Yes"
"HVTN 503","503-01288","Placebo","Yes","Female","Black","Medunsa",NA,33,"No","End of Study","No","vaccines on hold","Yes","Yes","Yes"
"HVTN 503","503-15738","Placebo","Yes","Female","Black","Medunsa",NA,32,"No","End of Study","No","vaccinations on hold","No","No","Yes"
"HVTN 503","503-14774","Vaccine","Yes","Female","Black","Medunsa",NA,23,"No","End of Study","No","vaccinations on hold","No","Yes","No"
"HVTN 503","503-05290","Vaccine","Yes","Female","Black","Medunsa",NA,23,"Yes","Other","No","study vaccinations on hold","No","Yes","No"
"HVTN 503","503-14982","Placebo","Yes","Male","Black","Medunsa","uncircumcised throughout the study",24,"No","End of Study","No","vaccinations stopped.","No","No","No"
"HVTN 503","503-03638","Placebo","Yes","Male","Black","Medunsa","uncircumcised throughout the study",21,"Yes","Unable to Contact Participant","No","study vaccinations stopped","No","Yes","No"
"HVTN 503","503-01741","Vaccine","Yes","Male","Black","Medunsa","circumcised at baseline",22,"No","End of Study","No","DSMB decision to discontinue vaccinations.","No","Yes","No"
"HVTN 503","503-07720","Vaccine","Yes","Male","Black","Medunsa","circumcised at baseline",25,"Yes","Participant Relocated","No","Unable to schedule","No","Yes","Yes"
"HVTN 503","503-07535","Vaccine","Yes","Male","Black","Medunsa","circumcised at baseline",30,"No","End of Study","No","vaccinations on hold","No","No","No"
"HVTN 503","503-06667","Vaccine","Yes","Male","Black","Medunsa","uncircumcised throughout the study",25,"No","End of Study","No","vaccination on hold","No","Yes","No"
"HVTN 503","503-10848","Vaccine","Yes","Male","Black","Medunsa","uncircumcised throughout the study",23,"No","End of Study","No","vaccination on hold DSMB decision to discontinue","Yes","Yes","No"
"HVTN 503","503-10084","Placebo","Yes","Male","Black","Medunsa","uncircumcised throughout the study",21,"No","End of Study","No","vaccinations on hold","No","Yes","No"
"HVTN 503","503-12690","Placebo","Yes","Male","Black","Medunsa","uncircumcised throughout the study",25,"Yes","Participant Relocated","No","vaccinations on hold","No","Yes","No"
"HVTN 503","503-05224","Placebo","Yes","Male","Black","Medunsa","uncircumcised throughout the study",19,"Yes","Unable to Contact Participant","No","vaccinations on hold","No","No","No"
"HVTN 503","503-02869","Placebo","Yes","Male","Black","Medunsa","uncircumcised throughout the study",25,"No","End of Study","No","vaccination on hold","Yes","Yes","No"
"HVTN 503","503-15383","Vaccine","Yes","Male","Black","Medunsa","uncircumcised throughout the study",32,"No","End of Study","No","vaccination on hold","Yes","Yes","No"
"HVTN 503","503-04784","Vaccine","Yes","Male","Black","Medunsa","uncircumcised throughout the study",23,"No","End of Study","No","study vaccinations stopped","No","Yes","Yes"
"HVTN 503","503-00463","Placebo","Yes","Male","Black","Medunsa","uncircumcised throughout the study",24,"Yes","Unable to Contact Participant","No","DSMB decision to discontinue vaccinations.","No","Yes","No"
"HVTN 503","503-05992","Vaccine","Yes","Male","Black","Medunsa","circumcised at baseline",21,"No","End of Study","No","Vaccinations stopped","No","Yes","No"
"HVTN 503","503-15308","Placebo","Yes","Male","Black","Medunsa","uncircumcised throughout the study",20,"No","End of Study","No","vaccinations on hold","No","Yes","No"
"HVTN 503","503-09930","Placebo","Yes","Male","Black","Medunsa","uncircumcised throughout the study",19,"No","End of Study","No","vaccines on hold","No","Yes","No"
"HVTN 503","503-03100","Vaccine","Yes","Male","Black","Medunsa","uncircumcised throughout the study",25,"No","End of Study","No","Unable to schedule","No","Yes","No"
"HVTN 503","503-12787","Vaccine","Yes","Male","Black","Medunsa","uncircumcised throughout the study",22,"No","End of Study","No","vaccination on hold","No","Yes","No"
"HVTN 503","503-11020","Placebo","Yes","Male","Black","Medunsa","circumcised at baseline",24,"No","End of Study","No","vaccines on hold","No","No","Yes"
"HVTN 503","503-06859","Placebo","Yes","Male","Black","Medunsa","uncircumcised throughout the study",22,"Yes","Unable to Contact Participant","No","DSMB decision to discontinue vaccinations.","No","Yes","No"
"HVTN 503","503-01840","Vaccine","Yes","Male","Black","Medunsa","circumcised on study",20,"No","End of Study","No","vaccines on hold","No","Yes","No"
"HVTN 503","503-06439","Vaccine","Yes","Male","Black","Medunsa","uncircumcised throughout the study",21,"Yes","Other","No","VACCINATIONS ON HOLD","No","Yes","No"
"HVTN 503","503-10405","Placebo","Yes","Male","Black","Medunsa","circumcised at baseline",33,"No","End of Study","No","vaccinations on hold","No","Yes","Yes"
"HVTN 503","503-05866","Vaccine","Yes","Male","Black","Medunsa","uncircumcised throughout the study",23,"No","End of Study","No","study vaccinations on hold","Yes","Yes","No"
"HVTN 503","503-09686","Placebo","Yes","Male","Black","Medunsa","uncircumcised throughout the study",22,"Yes","Participant Relocated","No","vaccines on hold","No","No","No"
"HVTN 503","503-03833","Placebo","Yes","Male","White","Medunsa","uncircumcised throughout the study",22,"Yes","Other","No","vaccinations on hold","No","No","No"
"HVTN 503","503-13704","Vaccine","Yes","Male","Black","Medunsa","uncircumcised throughout the study",20,"No","End of Study","No","vaccination on hold","No","Yes","Yes"
"HVTN 503","503-10577","Vaccine","Yes","Male","Black","Medunsa","circumcised at baseline",21,"No","End of Study","No","vaccinations on hold","No","Yes","No"
"HVTN 503","503-08323","Vaccine","Yes","Male","Black","Medunsa","uncircumcised throughout the study",29,"Yes","Unable to Contact Participant","No","vaccinations on hold","No","No","No"
"HVTN 503","503-02745","Vaccine","Yes","Male","Black","Medunsa","uncircumcised throughout the study",21,"No","End of Study","No","vaccinations on hold","No","Yes","No"
"HVTN 503","503-08351","Placebo","Yes","Male","Black","Medunsa","circumcised at baseline",22,"No","End of Study","No","vaccinations of hold","No","No","No"
"HVTN 503","503-00175","Placebo","Yes","Male","Black","Medunsa","uncircumcised throughout the study",18,"No","End of Study","No","vaccinations on hold","No","Yes","No"
"HVTN 503","503-15824","Vaccine","Yes","Male","Black","Medunsa","uncircumcised throughout the study",23,"Yes","Unable to Contact Participant","No","vaccines on hold","No","Yes","No"
"HVTN 503","503-12359","Placebo","Yes","Male","Black","Medunsa","uncircumcised throughout the study",19,"Yes","Unable to Contact Participant","No","vaccines on hold","No","No","No"
"HVTN 503","503-14473","Placebo","Yes","Male","Black","Medunsa","circumcised at baseline",24,"No","End of Study","No","vaccinations on hold","No","Yes","No"
"HVTN 503","503-10198","Vaccine","Yes","Male","Black","Medunsa","uncircumcised throughout the study",18,"No","End of Study","No","Vaccination stopped","No","Yes","No"
"HVTN 503","503-01323","Vaccine","Yes","Male","Black","Medunsa","circumcised at baseline",22,"No","End of Study","No","vaccinations on hold","No","Yes","No"
"HVTN 503","503-14234","Placebo","Yes","Male","Black","Medunsa","uncircumcised throughout the study",18,"Yes","Death","Yes","study vaccinations on hold","No","Yes","No"
"HVTN 503","503-08887","Placebo","Yes","Male","Black","Medunsa","uncircumcised throughout the study",23,"No","End of Study","No","vaccinations on hold","No","No","No"